# EDGAR Filing Document

**Accession Number:** 0001477294
**File Stem:** 0001477294-26-000018
**Filing Date:** 2026-4
**Character Count:** 189184
**Document Hash:** ab5b57b34f60775b6984acc765a1cbff
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477294-26-000018.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001477294-26-000018

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 83

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sensata Technologies Holding plc
- **CENTRAL INDEX KEY:** 0001477294
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 981386780
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34652
- **FILM NUMBER:** 26909318

**BUSINESS ADDRESS:**
- **STREET 1:** INTERFACE HOUSE, INTERFACE BUSINESS PARK
- **STREET 2:** BINCKNOLL LANE, ROYAL WOOTTON BASSETT
- **CITY:** SWINDON
- **STATE:** X0
- **ZIP:** SN4 8SY
- **BUSINESS PHONE:** 508-236-3800

**MAIL ADDRESS:**
- **STREET 1:** INTERFACE HOUSE, INTERFACE BUSINESS PARK
- **STREET 2:** BINCKNOLL LANE, ROYAL WOOTTON BASSETT
- **CITY:** SWINDON
- **STATE:** X0
- **ZIP:** SN4 8SY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sensata Technologies Holding N.V.
- **DATE OF NAME CHANGE:** 20100226

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sensata Technologies Holding B.V.
- **DATE OF NAME CHANGE:** 20091120

?xml version='1.0' encoding='ASCII'? st-20260331

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_________________________________________________________________________________

**FORM 10-Q** 

_________________________________________________________________________________

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended March 31, 2026**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**

**Commission File Number 001-34652** 

_________________________________________________________________________________

**SENSATA TECHNOLOGIES HOLDING PLC** 

(Exact name of registrant as specified in its charter)

_________________________________________________________________________________

---

| | |
|:---|:---|
| **England and Wales** | **98-1386780** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |

---

**529 Pleasant Street** 

**Attleboro, Massachusetts, 02703, United States** 

(Address of principal executive offices, including zip code)

+1 **(508) 236 3800** 

(Registrant's telephone number, including area code)

**Not applicable**

(Former name, former address and former fiscal year, if changed since last report)

_____________________________________

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of exchange on which registered** |
| Ordinary Shares - nominal value €0.01 per share | ST | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 16, 2026, 145,432,046 ordinary shares were outstanding.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| **PART I** | **PART I** | |
| Item 1. | <u>[Financial Statements (unaudited):](#i999f43933e1c498f83f7dc56fc492f04_13)</u> |  |
|  | <u>[Condensed Consolidated Balance Sheets as of](#i999f43933e1c498f83f7dc56fc492f04_16)[March](#i999f43933e1c498f83f7dc56fc492f04_16)[3](#i999f43933e1c498f83f7dc56fc492f04_16)[1](#i999f43933e1c498f83f7dc56fc492f04_16)[, 202](#i999f43933e1c498f83f7dc56fc492f04_16)[6](#i999f43933e1c498f83f7dc56fc492f04_16)[and December 31, 202](#i999f43933e1c498f83f7dc56fc492f04_16)[5](#i999f43933e1c498f83f7dc56fc492f04_16)</u> | <u>[3](#i999f43933e1c498f83f7dc56fc492f04_16)</u> |
|  | <u>[Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2026 and 2025](#i999f43933e1c498f83f7dc56fc492f04_19)</u> | <u>[4](#i999f43933e1c498f83f7dc56fc492f04_19)</u> |
|  | <u>[Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2026 and 2025](#i999f43933e1c498f83f7dc56fc492f04_22)</u> | <u>[5](#i999f43933e1c498f83f7dc56fc492f04_22)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025](#i999f43933e1c498f83f7dc56fc492f04_25)</u> | <u>[6](#i999f43933e1c498f83f7dc56fc492f04_25)</u> |
|  | <u>[Condensed Consolidated Statements of Changes in Shareholders' Equity for the Three Months Ended March 31, 2026 and 2025](#i999f43933e1c498f83f7dc56fc492f04_28)</u> | <u>[7](#i999f43933e1c498f83f7dc56fc492f04_28)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements](#i999f43933e1c498f83f7dc56fc492f04_34)</u> | <u>[8](#i999f43933e1c498f83f7dc56fc492f04_34)</u> |
| Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i999f43933e1c498f83f7dc56fc492f04_106)</u> | <u>[21](#i999f43933e1c498f83f7dc56fc492f04_106)</u> |
| Item 3. | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i999f43933e1c498f83f7dc56fc492f04_151)</u> | <u>[31](#i999f43933e1c498f83f7dc56fc492f04_151)</u> |
| Item 4. | <u>[Controls and Procedures](#i999f43933e1c498f83f7dc56fc492f04_154)</u> | <u>[31](#i999f43933e1c498f83f7dc56fc492f04_154)</u> |
| **PART II** | **PART II** |  |
| Item 1. | <u>[Legal Proceedings](#i999f43933e1c498f83f7dc56fc492f04_160)</u> | <u>[33](#i999f43933e1c498f83f7dc56fc492f04_160)</u> |
| Item 1A. | <u>[Risk Factors](#i999f43933e1c498f83f7dc56fc492f04_163)</u> | <u>[33](#i999f43933e1c498f83f7dc56fc492f04_163)</u> |
| Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i999f43933e1c498f83f7dc56fc492f04_166)</u> | <u>[33](#i999f43933e1c498f83f7dc56fc492f04_166)</u> |
| Item 3. | <u>[Defaults Upon Senior Securities](#i999f43933e1c498f83f7dc56fc492f04_169)</u> | <u>[33](#i999f43933e1c498f83f7dc56fc492f04_169)</u> |
| Item 5. | <u>[Other Information](#i999f43933e1c498f83f7dc56fc492f04_172)</u> | <u>[33](#i999f43933e1c498f83f7dc56fc492f04_172)</u> |
| Item 6. | <u>[Exhibits](#i999f43933e1c498f83f7dc56fc492f04_178)</u> | <u>[34](#i999f43933e1c498f83f7dc56fc492f04_178)</u> |
|  | <u>[Signatures](#i999f43933e1c498f83f7dc56fc492f04_181)</u> | <u>[35](#i999f43933e1c498f83f7dc56fc492f04_181)</u> |

---

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**PART I—FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

**SENSATA TECHNOLOGIES HOLDING PLC**

**Condensed Consolidated Balance Sheets**

*(In millions, except per share amounts)*

*(unaudited)*

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $635.1 | $573.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowances of $16.9 and $16.2 as of March 31, 2026 and December 31, 2025, respectively | 693.2 | 657.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 605.8 | 617.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 152.4 | 146.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total current assets** | 2086.6 | 1994.3 |
| Property, plant and equipment, net | 763.1 | 776.5 |
| Goodwill | 3158.2 | 3158.2 |
| Other intangible assets, net of accumulated amortization of $2,604.4 and $2,588.7 as of March 31, 2026 and December 31, 2025, respectively | 396.6 | 411.6 |
| Deferred income tax assets | 271.8 | 277.2 |
| Other assets | 138.6 | 133.9 |
| **Total assets** | $6815.0 | $6751.7 |
| **Liabilities and shareholders' equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt and finance lease obligations | $2.4 | $2.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 446.4 | 413.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 16.3 | 16.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 293.5 | 343.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total current liabilities** | 758.6 | 775.1 |
| Deferred income tax liabilities | 235.3 | 226.9 |
| Pension and other post-retirement benefit obligations | 39.5 | 39.1 |
| Finance lease obligations, less current portion | 18.5 | 18.9 |
| Long-term debt, net | 2829.4 | 2828.6 |
| Other long-term liabilities | 78.2 | 77.8 |
| **Total liabilities** | 3959.5 | 3966.3 |
| Commitments and contingencies (Note 11) |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary shares, €0.01 nominal value per share, 177.0 shares issued as of March 31, 2026 and December 31, 2025 | 2.3 | 2.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury shares, at cost, 31.9 and 31.2 shares as of March 31, 2026 and December 31, 2025, respectively | (1427.8) | (1402.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 1904.4 | 1897.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 2363.7 | 2295.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income/(loss) | 13.0 | (7.4) |
| **Total shareholders' equity** | 2855.5 | 2785.4 |
| **Total liabilities and shareholders' equity** | $6815.0 | $6751.7 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**SENSATA TECHNOLOGIES HOLDING PLC**

**Condensed Consolidated Statements of Operations**

*(In millions, except per share amounts)*

*(unaudited)*

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Net revenue | $934.8 | $911.3 |
| Operating costs and expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenue | 648.5 | 638.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 31.9 | 36.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 93.4 | 86.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 15.7 | 20.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring and other charges, net | 3.7 | 7.0 |
| Total operating costs and expenses | 793.2 | 789.1 |
| **Operating income** | 141.6 | 122.2 |
| Interest expense | (34.1) | (38.0) |
| Interest income | 3.9 | 4.3 |
| Other, net | 4.1 | 2.1 |
| **Income before taxes** | 115.5 | 90.6 |
| Provision for income taxes | 28.4 | 20.7 |
| **Net income** | $87.1 | $69.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Basic net income per share** | $0.60 | $0.47 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Diluted net income per share** | $0.59 | $0.47 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

**SENSATA TECHNOLOGIES HOLDING PLC**

**Condensed Consolidated Statements of Comprehensive Income** 

*(In millions)*

*(unaudited)*

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Net income | $87.1 | $69.9 |
| Other comprehensive income/(loss), net of tax: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash flow hedges | 11.4 | (4.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defined benefit and retiree healthcare plans | 0.0 | 0.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustment | 9.0 | 3.9 |
| Other comprehensive income/(loss) | 20.5 | (0.1) |
| **Comprehensive income** | $107.6 | $69.8 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

 **SENSATA TECHNOLOGIES HOLDING PLC**

**Condensed Consolidated Statements of Cash Flows**

*(In millions)*

*(unaudited)*

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| **Cash flows from operating activities:** | | |
| Net income | $87.1 | $69.9 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 34.0 | 41.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 1.1 | 1.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on sale of business |  | 3.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 6.8 | 6.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 15.7 | 20.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 10.0 | (6.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on equity investments, net | 0.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-cash loss, net | 1.8 | 5.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities, net of the effects of divestitures: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | (34.3) | (34.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 13.0 | (48.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other | (4.1) | (8.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (8.2) | 64.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | (0.5) | 2.6 |
| Net cash provided by operating activities | 122.5 | 119.2 |
| **Cash flows from investing activities:** |  |  |
| Additions to property, plant and equipment and capitalized software | (17.9) | (32.6) |
| Proceeds from the sale of business, net of cash sold |  | 25.6 |
| Other | 1.4 | 0.1 |
| Net cash used in investing activities | (16.5) | (6.9) |
| **Cash flows from financing activities:** |  |  |
| Payment of employee restricted stock tax withholdings | (1.6) | (0.1) |
| Payments on debt | (0.4) | (0.7) |
| Dividends paid | (17.5) | (17.9) |
| Payments to repurchase ordinary shares | (25.1) | (100.5) |
| Payments of debt financing costs | (0.1) |  |
| Net cash used in financing activities | (44.7) | (119.1) |
| Effect of exchange rate changes on cash and cash equivalents | 0.8 | 1.3 |
| Net change in cash and cash equivalents | 62.1 | (5.5) |
| Cash and cash equivalents, beginning of year | 573.0 | 593.7 |
| **Cash and cash equivalents, end of period** | $635.1 | $588.1 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**SENSATA TECHNOLOGIES HOLDING PLC**

**Condensed Consolidated Statements of Changes in Shareholders' Equity**

*(In millions)*

*(unaudited)* 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Ordinary Shares** | **Ordinary Shares** | **Treasury Shares** | **Treasury Shares** | **Additional Paid-In Capital** | **Retained Earnings** | **Accumulated Other Comprehensive (Loss)/ Income** | **Total Shareholders' Equity** |
| **Number** | **Amount** | **Number** | **Amount** | **Additional Paid-In Capital** | **Retained Earnings** | **Accumulated Other Comprehensive (Loss)/ Income** | **Total Shareholders' Equity** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Balance as of December 31, 2025** | **177.0** | $**2.3** | **(31.2)** | $**(1402.7)** | $**1897.6** | $**2295.6** | $**(7.4)** | $**2785.4** |
| Surrender of shares for tax withholding |  |  | (0.0) | (1.6) |  |  |  | (1.6) |
| Vesting of restricted securities | 0.1 | 0.0 |  |  |  | (0.0) |  |  |
| Cash dividends paid |  |  |  |  |  | (17.5) |  | (17.5) |
| Repurchase of ordinary shares |  |  | (0.7) | (25.1) |  |  |  | (25.1) |
| Retirement of ordinary shares | (0.0) | (0.0) | 0.0 | 1.6 |  | (1.6) |  |  |
| Share-based compensation |  |  |  |  | 6.8 |  |  | 6.8 |
| Net income |  |  |  |  |  | 87.1 |  | 87.1 |
| Other comprehensive income |  |  |  |  |  |  | 20.5 | 20.5 |
| **Balance as of March 31, 2026** | **177.0** | $**2.3** | **(31.9)** | $**(1427.8)** | $**1904.4** | $**2363.7** | $**13.0** | $**2855.5** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Balance as of December 31, 2024** | **176.5** | $**2.3** | **(27.0)** | $**(1282.1)** | $**1872.6** | $**2340.2** | $**(42.5)** | $**2890.4** |
| Surrender of shares for tax withholding |  |  | (0.0) | (0.1) |  |  |  | (0.1) |
| Vesting of restricted securities | 0.0 | 0.0 |  |  |  | (0.0) |  |  |
| Cash dividends paid |  |  |  |  |  | (17.9) |  | (17.9) |
| Repurchase of ordinary shares |  |  | (3.5) | (100.5) |  |  |  | (100.5) |
| Retirement of ordinary shares | (0.0) | (0.0) | 0.0 | 0.1 |  | (0.1) |  |  |
| Share-based compensation |  |  |  |  | 6.9 |  |  | 6.9 |
| Net income |  |  |  |  |  | 69.9 |  | 69.9 |
| Other comprehensive loss |  |  |  |  |  |  | (0.1) | (0.1) |
| **Balance as of March 31, 2025** | **176.5** | $**2.3** | **(30.5)** | $**(1382.6)** | $**1879.4** | $**2392.2** | $**(42.7)** | $**2848.6** |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**SENSATA TECHNOLOGIES HOLDING PLC**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

*(unaudited)*

**1. Basis of Presentation**

The accompanying unaudited condensed consolidated financial statements reflect the financial position, results of operations, comprehensive income, cash flows, and changes in shareholders' equity of Sensata Technologies Holding plc, a public limited company incorporated under the laws of England and Wales, and its consolidated subsidiaries, collectively referred to as the "Company," "Sensata," "we," "our," or "us."

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying interim financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC") on February 27, 2026 (the "2025 Annual Report").

In the three months ended December 31, 2025, we realigned our business as a result of organizational changes that better allocate our resources to support changes to our business strategy. These changes resulted in the dissolution of our prior segments, Performance Sensing and Sensing Solutions, and the creation of three new segments. Our Automotive segment includes both Automotive and Aftermarket businesses. The Industrials segment includes our Industrial and Dynapower businesses. The Aerospace, Defense, and Commercial Equipment segment includes our Aerospace and Commercial Equipment businesses. Our new operating structure allows us to more effectively allocate capital and investment dollars based on different end market and growth dynamics in each of these segments. Prior period amounts in this Quarterly Report on Form 10-Q have been recast to reflect this realignment and to conform to current year presentation. Refer to *Note 15: Segment Reporting* for additional information.

All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in millions, unless otherwise indicated. We round amounts in the consolidated financial statements within tables and text (unless otherwise specified) and calculate all percentages and per-share data from underlying whole-dollar amounts. Thus, certain amounts may not foot, crossfoot, or recalculate based on reported numbers due to rounding. Certain reclassifications have been made to prior periods to conform to current period presentation.

**2. New Accounting Standards**

In November 2024, the FASB issued ASU No. 2024-03 *Income Statement (Topic 220): Reporting Comprehensive Income*, which requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement*.* ASU No. 2024-03 does not change or remove current expense presentation requirements within the Consolidated Statements of Operations. However, the update requires disclosure, on an annual and interim basis, of disaggregated information about certain income statement expense line items within the notes to the consolidated financial statements. This ASU is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of ASU No. 2024-03 will have on its consolidated financial statements and disclosures.

In September 2025, the FASB issued ASU No. 2025-06, *Intangibles-Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.* This update improves the operability of the guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. ASU No. 2025-06 is effective for annual reporting periods beginning after December 15, 2027, including interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. This ASU can be applied prospectively, retrospectively, or with a modified transition approach. The Company is currently evaluating the impact that the adoption of ASU No. 2025-06 will have on its consolidated financial statements and disclosures.

In November 2025, the FASB issued ASU 2025-09, *Derivatives and Hedging (Topic 815): Hedge Accounting Improvements.* This guidance amends existing guidance to simplify the application of hedge accounting, enhance alignment between risk management activities and financial reporting, and provide additional flexibility in the designation and measurement of certain hedging relationships. The amendments included in the five matters addressed in this ASU are intended to better reflect those strategies in financial reporting by enabling entities to achieve and maintain hedge accounting for highly effective economic

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

hedges of forecasted transactions. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact that the adoption of ASU No. 2025-09 will have on its consolidated financial statements and disclosures.

**3. Revenue Recognition**

We recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods. The majority of our revenue is derived from the sale of tangible products whereby (1) control of the product transfers to the customer at a point in time, (2) we recognize revenue at a point in time, and (3) the underlying contract is a purchase order that establishes a firm purchase commitment for a short period of time. Our standard terms of sale provide our customers with a limited warranty against faulty workmanship and the use of defective materials.

We have elected to apply certain practical expedients that allow for more limited disclosures than those that would otherwise be required by FASB ASC Topic 606, including (1) the disclosure of transaction price allocated to the remaining unsatisfied performance obligations at the end of the period and (2) an explanation of when we expect to recognize the related revenue.

We believe that our geographic regions are the categories that best depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Refer to *Note 15: Segment Reporting* for additional information.

**4. Share-Based Payment Plans**

The following table presents the components of non-cash compensation expense related to our equity awards for the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Restricted securities  | $6.8 | $6.9 |
| Share-based compensation expense | $6.8 | $6.9 |

---

**5. Restructuring and Other Charges, Net**

*Transformation Plan*

In the year ended December 31, 2025, we committed to a plan to reorganize our business (the "Transformation Plan"). The Transformation Plan, consisting of leadership transitions, involuntary reductions-in-force, site closures, and other cost-savings initiatives, was commenced to competitively reposition ourselves to capture growth from evolving market conditions.

Over the life of the Transformation Plan, we expect to incur restructuring charges of between $13.0 million and $16.0 million, primarily related to reductions-in-force and related site closure costs. All restructuring costs are excluded from segment results. The majority of the actions under the Transformation Plan are expected to be completed on or before June 30, 2028. We expect to settle these charges with cash on hand.

*2H 2024 Plan*

In the year ended December 31, 2024, we committed to a plan to reorganize our business (the "2H 2024 Plan"). The 2H 2024 Plan, consisting of involuntary reductions-in-force, site closures, and other cost-savings initiatives, was commenced to adjust our cost structure and business activities to better align with weaker market demand and continued economic uncertainty in many of our end markets and to take active measures to accelerate our margin recovery.

Over the life of the 2H 2024 Plan, we expect to incur restructuring charges of approximately $18.0 million, primarily related to reductions-in-force. The majority of the actions under the 2H 2024 Plan were completed on or before December 31, 2025 and actions yet to be completed are expected to result in immaterial charges. We expect to settle these charges with cash on hand.

*Q3 2023 Plan*

In the year ended December 31, 2023, we committed to a plan to reorganize our business (the "Q3 2023 Plan"). The Q3 2023 Plan, consisting of voluntary and involuntary reductions-in-force, site closures, and other cost-savings initiatives, was commenced to adjust our cost structure and business activities to better align with weaker market demand and continued economic uncertainty in many of our end markets and to take active measures to accelerate our margin recovery.

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

Over the life of the Q3 2023 Plan, we expect to incur restructuring charges of approximately $29.0 million, primarily related to reductions-in-force. The majority of the actions under the Q3 2023 Plan were completed on or before December 31, 2025 and actions yet to be completed are expected to result in immaterial charges. We expect to settle these charges with cash on hand.

*Summary*

The following table presents the components of restructuring and other charges, net for the three months ended March 31, 2026, and 2025:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Transformation Plan | $4.4 | $— |
| 2H 2024 Plan, net  | 0.2 | 2.5 |
| Q3 2023 Plan, net | 0.2 | 0.9 |
| Other restructuring and other charges, net |  |  |
| &nbsp;&nbsp;Severance charges, net  | (0.1) | (0.1) |
| &nbsp;&nbsp;Transaction related charges | (1.0) | 4.4 |
| &nbsp;&nbsp;Facility and other charge |  | (0.7) |
| Restructuring and other charges, net | $3.7 | $7.0 |

---

The following table presents a rollforward of our severance liability, which is primarily related to the Transformation Plan, for the three months ended March 31, 2026:

---

| | |
|:---|:---|
| | **Total** |
| Balance as of December 31, 2025 | $4.8 |
| Charges, net of reversals | 1.9 |
| Payments | (2.6) |
| Foreign currency remeasurement |  |
| Balance as of March 31, 2026 | $4.1 |

---

The severance liability as of March 31, 2026 and December 31, 2025 was entirely recorded in accrued expenses and other current liabilities on our condensed consolidated balance sheets.

**6. Other, Net** 

The following table presents the components of other, net for the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Currency remeasurement gain/(loss) on net monetary assets | $0.0 | $(0.5) |
| Loss on foreign currency forward contracts | (0.0) | (1.6) |
| Gain on commodity forward contracts | 4.6 | 4.4 |
| Net periodic benefit cost, excluding service cost | (0.9) | (0.5) |
| Other | 0.3 | 0.3 |
| Other, net | $4.1 | $2.1 |

---

**7. Income Taxes**

The following table presents the provision for income taxes for the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Provision for income taxes | $28.4 | $20.7 |

---

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

The provision for income taxes consists of (1) current tax expense, which relates primarily to our profitable operations in tax jurisdictions with limited or no net operating loss carryforwards and withholding taxes related to management fees, royalties, and the repatriation of foreign earnings; and (2) deferred tax expense (or benefit), which represents adjustments in book-to-tax basis differences primarily related to (a) book versus tax basis in intangible assets, (b) changes in net operating loss carryforwards and tax credits, and (c) changes in withholding taxes on unremitted earnings.

In July 2025, the U.S. enacted Public Law 119-21 (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) (commonly referred to as the "One Big Beautiful Bill"). The legislation includes multiple tax provisions with varying effective dates, with certain provisions effective January 1, 2025 and others becoming effective in later periods, including through 2027.

The Company is continuing to evaluate the provisions of the legislation, including available elections, interpretive guidance, and the related impacts on its consolidated financial statements and disclosures. While the Company does not currently expect the adoption of Public Law 119-21 to have a material adverse impact on its consolidated financial statements, the assessment of certain provisions is ongoing and may be affected by future guidance, elections made by the Company, or other developments.

**8. Net Income per Share**

Basic and diluted net income per share are calculated by dividing net income by the number of basic and diluted weighted-average ordinary shares outstanding during the period. For the three months ended March 31, 2026 and 2025 the weighted-average ordinary shares outstanding used to calculate basic and diluted net income per share were as follows:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Basic weighted-average ordinary shares outstanding | 145.6 | 148.5 |
| Dilutive effect of unvested restricted securities | 1.0 | 0.3 |
| Diluted weighted-average ordinary shares outstanding | 146.6 | 148.8 |

---

Net income and net income per share are presented in the condensed consolidated statements of operations.

Certain potential ordinary shares were excluded from our calculation of diluted weighted-average ordinary shares outstanding because either they would have had an anti-dilutive effect on net income per share or they related to equity awards that were contingently issuable for which the contingency had not been satisfied. These potential ordinary shares were as follows:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Anti-dilutive shares excluded | 0.5 | 1.1 |
| Contingently issuable shares excluded | 0.9 | 0.7 |

---

**9. Inventories**

The following table presents the components of inventories as of March 31, 2026 and December 31, 2025:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Finished goods | $191.4 | $196.6 |
| Work-in-process | 152.6 | 144.8 |
| Raw materials | 261.8 | 276.4 |
| Inventories | $605.8 | $617.8 |

---

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

**10. Debt** 

The following table presents the components of long-term debt, net and finance lease obligations as of March 31, 2026 and December 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| | **Maturity Date** | **March 31,<br>2026** | **December 31,<br>2025** |
| 4.0% Senior Notes | April 15, 2029 | $646.0 | $646.0 |
| 4.375% Senior Notes | February 15, 2030 | 450.0 | 450.0 |
| 5.875% Senior Notes | September 1, 2030 | 500.0 | 500.0 |
| 3.75% Senior Notes | February 15, 2031 | 750.0 | 750.0 |
| 6.625% Senior Notes | July 15, 2032 | 500.0 | 500.0 |
| Plus: debt premium, net of discount |  | 0.4 | 0.5 |
| Less: deferred financing costs |  | (17.1) | (17.9) |
| Long-term debt, net |  | $2829.4 | $2828.6 |
| Finance lease obligations |  | $20.9 | $21.2 |
| Less: current portion |  | (2.4) | (2.3) |
| Finance lease obligations, less current portion |  | $18.5 | $18.9 |

---

Our indebtedness as of March 31, 2026 and December 31, 2025 consists of various tranches of senior unsecured notes as shown in the table above. We also have secured credit facilities (the "Senior Secured Credit Facilities") which provide for our $650.0 million revolving credit facility (the "Revolving Credit Facility") and incremental availability under which additional debt can be issued. Refer to *Note 14: Debt* of our 2025 Annual Report for additional information related to our indebtedness.

*Revolving Credit Facility*

As of March 31, 2026, we had $645.8 million available under the Revolving Credit Facility, net of $4.2 million of obligations in respect of outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of March 31, 2026, no amounts had been drawn against these outstanding letters of credit.

During April 2026, the Company entered into a technical amendment to the Revolving Credit Facility correcting and clarifying certain details to conform the language with the intention of the Fourteenth Amendment that was signed in September 2025.

***Accrued Interest***

Accrued interest associated with our outstanding debt is included as a component of accrued expenses and other current liabilities in the condensed consolidated balance sheets. As of March 31, 2026 and December 31, 2025, accrued interest totaled $27.5 million and $48.6 million, respectively.

**11. Commitments and Contingencies** 

We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial condition, and/or cash flows.

***Other Matters***

Following the February 2026 ruling by the United States Supreme Court striking down certain tariffs imposed under the International Emergency Economic Powers Act, U.S. Customs and Border Protection has since announced steps toward an administrative process to address potential tariff refunds. However, the availability, timing, and amount of any potential refunds remain uncertain and are subject to ongoing legal, regulatory, and administrative developments.

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

**12. Shareholders' Equity**

***Cash Dividends***

In the three months ended March 31, 2026 and 2025, we paid aggregate cash dividends of $17.5 million and $17.9 million, respectively. In April 2026, we announced that our Board of Directors approved a quarterly dividend of $0.12 per share, payable in May 2026 to shareholders of record as of May 13, 2026.

***Treasury Shares***

From time to time, our Board of Directors has authorized various share repurchase programs, which may be modified or terminated by the Board at any time. Under these programs, we may repurchase ordinary shares at such times and in amounts to be determined by our management, based on market conditions, legal requirements, and other corporate considerations, on the open market or in privately negotiated transactions, provided that such transactions were completed pursuant to an agreement and with a third party approved by our shareholders at the annual general meeting. Ordinary shares repurchased by us are recognized, measured at cost, and presented as treasury shares on our consolidated balance sheets, resulting in a reduction of shareholders' equity. In September 2023, our Board of Directors authorized a $500.0 million ordinary share repurchase program (the "September 2023 Program"), which became effective on October 1, 2023.

In the three months ended March 31, 2026 and 2025, we repurchased 0.7 million and 3.5 million ordinary shares for $25.1 million and $100.5 million, respectively. All share repurchases in the three months ended March 31, 2026 and 2025 were made under the September 2023 Program. As of March 31, 2026, $257.3 million remained available for repurchase under the September 2023 Program.

***Accumulated Other Comprehensive Income/(Loss)***

The following table presents the components of accumulated other comprehensive income/(loss) for the three months ended March 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Cash Flow Hedges** | **Defined Benefit and Retiree Healthcare Plans** | **Cumulative Translation Adjustment** | **Accumulated Other Comprehensive Income/(Loss)** |
| Balance as of December 31, 2025 | $0.5 | $(10.3) | $2.3 | $(7.4) |
| Other comprehensive income before reclassifications, net of tax | 8.6 |  | 9.0 | 17.6 |
| Reclassifications from accumulated other comprehensive income/(loss), net of tax | 2.8 | 0.0 |  | 2.8 |
| Other comprehensive income | 11.4 | 0.0 | 9.0 | 20.5 |
| Balance as of March 31, 2026 | $11.9 | $(10.3) | $11.3 | $13.0 |

---

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

The following table presents the amounts reclassified from accumulated other comprehensive income/(loss) for the three months ended March 31, 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
| | **For the three months ended March 31,** | **For the three months ended March 31,** | **Affected Line in Condensed Consolidated Statements of Operations** |
|<br>**Component** | **2026** | **2025** | **Affected Line in Condensed Consolidated Statements of Operations** |
| **Derivative instruments designated and qualifying as cash flow hedges:** | **Derivative instruments designated and qualifying as cash flow hedges:** | **Derivative instruments designated and qualifying as cash flow hedges:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency forward contracts | $5.2 | $(5.0) | Net revenue <sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency forward contracts | (1.3) | 3.1 | Cost of revenue <sup>(1)</sup> |
| Total, before taxes | 3.8 | (1.9) | Income before taxes |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect | (1.0) | 0.5 | Provision for income taxes |
| Total, net of taxes | $2.8 | $(1.4) | Net income |
| **Defined benefit and retiree healthcare plans** |  |  |  |
| &nbsp;&nbsp;&nbsp;Defined benefit and retiree healthcare plans | $0.0 | $(0.0) | Other, net |
| &nbsp;&nbsp;&nbsp;Defined benefit and retiree healthcare plans |  | 0.7 | Restructuring and other charges, net |
| Total, before taxes | 0.0 | 0.7 | Income before taxes |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax effect | (0.0) | (0.2) | Provision for income taxes |
| Total, net of taxes | $0.0 | $0.5 | Net income |

---

___________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Refer to *Note 14: Derivative Instruments and Hedging Activities* for additional information regarding amounts to be reclassified from accumulated other comprehensive income/(loss) in future periods.

**13. Fair Value Measures**

***Measured on a Recurring Basis***

The fair values of our assets and liabilities measured at fair value on a recurring basis as of March 31, 2026 and December 31, 2025 are shown in the below table.

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets** | | |
| Cash equivalents (Level 1) | $417.5 | $406.1 |
| Foreign currency forward contracts (Level 2) | 22.4 | 18.3 |
| Commodity forward contracts (Level 2) | 18.6 | 21.2 |
| Total | $458.6 | $445.6 |
| **Liabilities** |  |  |
| Foreign currency forward contracts (Level 2) | $8.5 | $17.4 |
| Commodity forward contracts (Level 2) |  | 0.3 |
| Total | $8.5 | $17.7 |

---

Refer to *Note 14: Derivative Instruments and Hedging Activities* for additional information regarding our forward contracts. Cash equivalents consist of U.S. Government Treasury money market funds and are classified as Level 1 as they are exchange traded in an active market.

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

***Financial Instruments Not Recorded at Fair Value***

The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025. All fair value measures presented are categorized in Level 2 of the fair value hierarchy.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
| | **Carrying Value**<sup>(1)</sup> | **Fair Value** | **Carrying Value**<sup>(1)</sup>  | **Fair Value** |
| **Liabilities** | | | | |
| 4.0% Senior Notes | $646.0 | $623.6 | $646.0 | $632.2 |
| 4.375% Senior Notes | $450.0 | $431.1 | $450.0 | $439.8 |
| 5.875% Senior Notes | $500.0 | $500.4 | $500.0 | $507.9 |
| 3.75% Senior Notes | $750.0 | $693.8 | $750.0 | $703.1 |
| 6.625% Senior Notes | $500.0 | $510.8 | $500.0 | $523.8 |

---

___________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Excluding any related debt discounts, premiums, and deferred financing costs.

In addition to the above, we hold certain equity investments that do not have readily determinable fair values for which we use the measurement alternative prescribed in FASB ASC Topic 321. Such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. As of March 31, 2026 and December 31, 2025, we held equity investments under the measurement alternative of $7.3 million, which are presented in other assets in the condensed consolidated balance sheets.

**14. Derivative Instruments and Hedging Activities** 

***Foreign Currency Derivatives***

As of March 31, 2026, we had the following outstanding foreign currency forward contracts, which had the below hedge accounting designation in accordance with FASB ASC Topic 815, *Derivatives and Hedging*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Notional<br>(in millions)** | **Effective Date(s)** | **Maturity Date(s)** | **Index (Exchange Rates)** | **Weighted-Average Strike Rate** | **Hedge** <br>**Designation** <sup>(1)</sup> |
| 387.9 EUR | Various from April 2024 to March 2026 | Various from April 2026 to March 2028 | Euro ("EUR") to USD | 1.16 USD | Cash flow hedge |
| 3,848.6 MXN | Various from April 2024 to March 2026 | Various from April 2026 to March 2028 | USD to Mexican Peso ("MXN") | 19.96 MXN | Cash flow hedge |
| 66.3 GBP | Various from April 2024 to March 2026 | Various from April 2026 to March 2028 | British Pound Sterling ("GBP") to USD | 1.32 USD | Cash flow hedge |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Notional<br>(in millions)** | **Effective Date(s)** | **Maturity Date(s)** | **Index (Exchange Rates)** | **Weighted-Average Strike Rate** | **Hedge** <br>**Designation** <sup>(1)</sup> |
| 21.5 USD | Various from April 2024 to May 2024 | Various from April 2026 to May 2026 | USD to Chinese Renminbi ("CNY") | 6.97 CNY | Not designated |
| 149.8 CNY | Various September 2024 | Various from April 2026 to May 2026 | USD to CNY | 6.74 CNY | Not designated |
| 3,515.3 KRW | Various from May 2024 to September 2024 | Various from April 2026 to July 2026 | USD to Korean Won ("KRW") | 1,316.49 KRW | Not designated |

---

___________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve economic value, and they are not used for trading or speculative purposes.

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

As of March 31, 2026, we estimate that $12.0 million of net gain will be reclassified from accumulated other comprehensive income/(loss) to earnings during the twelve-month period ending March 31, 2027.

***Financial Instrument Presentation***

The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Asset Derivatives** | **Asset Derivatives** | **Asset Derivatives** | **Liability Derivatives** | **Liability Derivatives** | **Liability Derivatives** |
| | **Balance Sheet Location** | **March 31,<br>2026** | **December 31,<br>2025** | **Balance Sheet Location** | **March 31,<br>2026** | **December 31,<br>2025** |
| **Derivatives designated as hedging instruments** | **Derivatives designated as hedging instruments** | **Derivatives designated as hedging instruments** | **Derivatives designated as hedging instruments** | | | |
| Foreign currency forward contracts | Prepaid expenses and other current assets | $17.2 | $14.9 | Accrued expenses and other current liabilities | $6.5 | $13.8 |
| Foreign currency forward contracts | Other assets | 5.2 | 3.4 | Other long-term liabilities | 1.2 | 1.7 |
| Total |  | $22.4 | $18.3 |  | $7.7 | $15.5 |
| **Derivatives not designated as hedging instruments** | **Derivatives not designated as hedging instruments** | **Derivatives not designated as hedging instruments** |  |  |  |  |
| Commodity forward contracts | Prepaid expenses and other current assets | $16.5 | $17.0 | Accrued expenses and other current liabilities | $— | $0.3 |
| Commodity forward contracts | Other assets | 2.1 | 4.2 | Other long-term liabilities |  |  |
| Foreign currency forward contracts | Prepaid expenses and other current assets |  | 0.4 | Accrued expenses and other current liabilities | 0.9 | 2.3 |
| Total |  | $18.6 | $21.6 |  | $0.9 | $2.6 |

---

These fair value measurements were all categorized within Level 2 of the fair value hierarchy.

The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the three months ended March 31, 2026 and 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Derivatives designated as<br>hedging instruments** | **Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income/(Loss)** | **Amount of Deferred Gain/(Loss) Recognized in Other Comprehensive Income/(Loss)** | **Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income** | **Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income** | **Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income** |
| **Derivatives designated as<br>hedging instruments** | **2026** | **2025** | **Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Income/(Loss) into Net Income** | **2026** | **2025** |
| Foreign currency forward contracts | $10.8 | $(11.7) | Net revenue | $(5.2) | $5.0 |
| Foreign currency forward contracts | $0.7 | $7.5 | Cost of revenue | $1.3 | $(3.1) |

---

---

| | | | |
|:---|:---|:---|:---|
| **Derivatives not designated as<br>hedging instruments** | **Amount of Gain/(Loss) Recognized in Net Income** | **Amount of Gain/(Loss) Recognized in Net Income** | **Location of Gain/(Loss) Recognized in Net Income** |
| **Derivatives not designated as<br>hedging instruments** | **2026** | **2025** | **Location of Gain/(Loss) Recognized in Net Income** |
| Commodity forward contracts | $4.6 | $4.4 | Other, net |
| Foreign currency forward contracts | $(0.0) | $(1.6) | Other, net |

---

***Credit Risk Related Contingent Features***

We have agreements with our derivative counterparties that contain a provision whereby if we default on our indebtedness and repayment of the indebtedness has been accelerated by the lender, then we could also be declared in default on our derivative obligations.

As of March 31, 2026, the termination value of outstanding derivatives in a liability position, excluding any adjustment for non-performance risk, was $8.7 million. As of March 31, 2026, we had not posted any cash collateral related to these agreements. If we breach any of the default provisions on any of our indebtedness as described above, we could be required to settle our obligations under the derivative agreements at their termination values.

**15. Segment Reporting**

We present financial information for three reportable segments, Automotive, Industrials, and Aerospace, Defense, and Commercial Equipment. In the last quarter of 2025, we realigned our segments as a result of organizational changes that better

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

allocate our resources to support changes to our business strategy. Refer to *Note 1: Basis of Presentation* for additional information. Our operating segments are business segments that we manage as components of an enterprise, for which separate financial information is evaluated regularly by our chief operating decision maker ("CODM"), who is our chief executive officer, in deciding how to allocate resources and assess performance.

An operating segment's performance is primarily evaluated based on segment operating income, which excludes amortization of intangible assets, impairment of goodwill and other intangible assets, restructuring charges, and certain corporate costs or credits not associated with the operations of the segment. Corporate and other costs excluded from a segment's performance are separately stated below and include costs that are related to functional areas such as finance, information technology, legal, and human resources. The CODM uses operating income primarily in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis for operating income when making decisions about the allocation of operating and capital resources to each segment. Significant expenses reviewed by the CODM are segment cost of revenue and segment operating expenses. We believe that segment operating income, as defined above, is an appropriate measure for evaluating the operating performance of our segments. However, the measure should be considered in addition to, and not as a substitute for, or superior to, operating income or other measures of financial performance prepared with U.S. GAAP. The accounting policies of each of our operating and reportable segments are materially consistent with those described in *Note 2: Significant Accounting Policies* of the audited consolidated financial statements and notes thereto included in our 2025 Annual Report.

The Automotive segment primarily serves the Automotive OEM and aftermarket industries through the development and manufacturing of sensors, high-voltage solutions (i.e., electrical protection components), and other solutions that are used in mission-critical systems and applications.

Industrials primarily serves industrial customers through the development and manufacturing of a broad portfolio of application-specific sensor, power management, and electrical protection products used in a diverse range of industrial markets, including the appliance, HVAC, material handling, charging infrastructure, renewable energy generation, and microgrid applications and markets.

The Aerospace, Defense, and Commercial Equipment segment primarily serves the aerospace, including commercial aircraft, defense, and commercial equipment, which includes on-road truck, construction, and agriculture markets, through the development and manufacture of a variety of sensors, electrical protection products, operator controls, and other solutions that

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

are used in mission-critical systems and applications.

The following table presents net revenue, segment and non-segment operating expenses, and segment and non-segment operating income for the reportable segments and other operating results not allocated to our reportable segments for the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| **Net revenue:** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Automotive <sup>(1)</sup> | $524.8 | $528.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials <sup>(1)</sup> | 184.2 | 185.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aerospace, Defense, and Commercial Equipment <sup>(1)</sup> | 225.8 | 196.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net revenue | $934.8 | $911.3 |
| Segment cost of revenue: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Automotive | $359.1 | $369.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 110.0 | 113.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aerospace, Defense, and Commercial Equipment | 145.9 | 129.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total segment cost of revenue | $615.0 | $612.3 |
| **Segment operating expenses**<sup>(2)</sup>**:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Automotive <sup>(1)</sup> | $42.5 | $38.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials <sup>(1)</sup> | 24.2 | 24.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aerospace, Defense, and Commercial Equipment <sup>(1)</sup> | 16.4 | 17.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total segment operating expenses | $83.1 | $80.0 |
| **Segment operating income (as defined above):** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Automotive <sup>(1)</sup> | $123.2 | $120.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials <sup>(1)</sup> | 50.0 | 48.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aerospace, Defense, and Commercial Equipment <sup>(1)</sup> | 63.5 | 50.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total segment operating income | 236.7 | 218.9 |
| Corporate and other<sup>(1)</sup> | (75.7) | (69.2) |
| Amortization of intangible assets | (15.7) | (20.6) |
| Restructuring and other charges, net | (3.7) | (7.0) |
| Operating income | 141.6 | 122.2 |
| Interest expense | (34.1) | (38.0) |
| Interest income | 3.9 | 4.3 |
| Other, net | 4.1 | 2.1 |
| Income before taxes | $115.5 | $90.6 |

---

___________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The amounts previously reported for the three months ended March 31, 2025 have been retrospectively recast to reflect the segment realignment as discussed in *Note 1: Basis of Presentation*.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Segment operating expenses include research, development, and engineering, and selling, general and administrative expenses associated with each segment.

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

The following table presents depreciation and amortization expense for our reportable segments and corporate and other for the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Depreciation and amortization: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Automotive | $19.9 | $21.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 2.7 | 2.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aerospace, Defense, and Commercial Equipment | 4.2 | 4.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and other <sup>(1)</sup> | 23.0 | 32.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total depreciation and amortization | $49.8 | $61.6 |

---

__________________________

<sup>(1)</sup> Included within corporate and other is depreciation expense, amortization of intangible assets, and accelerated depreciation recognized in connection with restructuring actions. We do not allocate these amounts to our segments. This treatment is consistent with the financial information reviewed by our chief operating decision maker.

The following table presents additions to PP&E and capitalized software for our reportable segments and corporate and other for the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Additions to property, plant and equipment and capitalized software: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Automotive | $12.9 | $22.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 2.8 | 3.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Aerospace, Defense, and Commercial Equipment | 0.3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and other | 1.9 | 6.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total additions to property, plant and equipment and capitalized software | $17.9 | $32.6 |

---

***Geographic Area Information***

The following tables present net revenue by geographic area and by significant country for the three months ended March 31, 2026 and 2025. In these tables, net revenue is aggregated according to the location of our subsidiaries.

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Net revenue: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Americas | $375.7 | $372.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Europe | 268.0 | 252.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asia and rest of world | 291.1 | 286.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net revenue | $934.8 | $911.3 |

---

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2025** |
| Net revenue: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;United States | $365.7 | $345.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;China | 168.4 | 174.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;The Netherlands | 228.2 | 217.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;United Kingdom | 30.0 | 26.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;All other | 142.5 | 147.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net revenue | $934.8 | $911.3 |

---

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

The following tables present PP&E, net, by geographic area and by significant country as of March 31, 2026 and December 31, 2025. In these tables, PP&E, net is aggregated based on the location of our subsidiaries.

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Property, plant and equipment, net: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Americas | $257.3 | $262.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Europe | 130.9 | 135.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asia and rest of world | 375.0 | 378.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | $763.1 | $776.5 |

---

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Property, plant and equipment, net: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;United States | $96.4 | $99.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;China | 251.8 | 254.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mexico | 160.7 | 162.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bulgaria | 96.4 | 99.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;United Kingdom | 22.8 | 24.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Malaysia | 119.4 | 120.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;All other | 15.7 | 15.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | $763.1 | $776.5 |

---

**16. Disposals**

***Magnetic Speed and Position Business ("MSP Business")***

In November 2024, we executed a purchase agreement whereby we agreed to sell the MSP Business to a third party. The closing of the transaction occurred in the first quarter of 2025, at which time net assets transferred to the Buyer.

------

<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>

**Cautionary Statements Concerning Forward-Looking Statements**

This Quarterly Report on Form 10-Q includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by terminology such as "may," "will," "could," "should," "expect," "anticipate," "believe," "estimate," "predict," "project," "forecast," "continue," "intend," "plan," "potential," "opportunity," "guidance," and similar terms or phrases. Forward-looking statements involve, among other things, expectations, projections, and assumptions about future financial and operating results, objectives, business and market outlook, trends, priorities, growth, shareholder value, capital expenditures, cash flows, demand for products and services, share repurchases, and Sensata's strategic initiatives, including those relating to acquisitions and dispositions and the impact of such transactions on our strategic plans, operational plans, and financial results. These statements are subject to risks, uncertainties, and other important factors relating to our operations and business environment, and we can give no assurances that these forward-looking statements will prove to be correct.

A wide variety of potential risks, uncertainties, and other factors could materially affect our ability to achieve the results either expressed or implied by these forward-looking statements, including, but not limited to, risks related to instability and changes in the global markets, supplier interruption or non-performance, changes in trade-related tariffs and risks with uncertain trade environments, the acquisition or disposition of businesses, variability in metals pricing, cybersecurity, adverse conditions or competition in the industries upon which we are dependent, intellectual property, product liability, warranty, and recall claims, public health crises, market acceptance of new product introductions and product innovations, labor disruptions or increased labor costs, and changes in existing environmental or safety laws, regulations, and programs.

Investors and others should carefully consider the foregoing factors and other uncertainties, risks, and potential events including, but not limited to, those described in *Item 1A: Risk Factors* included in our 2025 Annual Report and as may be updated from time to time in *Item 1A: Risk Factors* included in our quarterly reports on Form 10-Q or other subsequent filings with the United States Securities and Exchange Commission. All such forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update these statements other than as required by law.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

The following discussion and analysis of our financial condition and results of operations supplements should be read in conjunction with the discussion in *Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations* included in our 2025 Annual Report. The following discussion should also be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto (the "Financial Statements") included elsewhere in this Report. Amounts and percentages in the following discussions and tables have been calculated based on unrounded numbers. Accordingly, certain amounts may not appear to recalculate due to the effect of rounding.

***Overview***

Net revenue for the three months ended March 31, 2026 was $934.8 million, an increase of 2.6% on a reported basis compared to $911.3 million in the prior period. Excluding an increase of 2.2% attributed to changes in foreign currency exchange rates and a decrease of 3.8% related to the effect of disposals, net revenue increased 4.2% on an organic basis. Organic revenue growth (or decline), discussed throughout this *Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations* (this "MD&A"), is a financial measure not presented in accordance with U.S. GAAP. Refer to *Non-GAAP Financial Measures* included elsewhere in this MD&A for additional information regarding our use of organic revenue growth (or decline).

Operating income for the three months ended March 31, 2026 was $141.6 million (15.2% of net revenue), an increase of $19.5 million, or 15.9% compared to operating income of $122.2 million (13.4% of net revenue) in the three months ended March 31, 2025. Refer to *Results of Operations* included elsewhere in this MD&A for additional discussion of our earnings results for the three months ended March 31, 2026 compared to the prior periods.

We generated $122.5 million of operating cash flows in the three months ended March 31, 2026, ending the quarter with $635.1 million in cash and cash equivalents. In the three months ended March 31, 2026, we used cash of approximately $17.9 million for capital expenditures, $17.5 million for payment of dividends, and $25.1 million for share repurchases as part of our share repurchase plan.

***Results of Operations***

The table below presents our historical results of operations, in millions of dollars and as a percentage of net revenue, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. We have derived the results of operations from the Financial Statements included elsewhere in this Report. Amounts and percentages in the table below have

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

been calculated based on unrounded numbers. Accordingly, certain amounts may not appear to recalculate due to the effect of rounding.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** |
| | **Amount** | **Percent** | **Amount** | **Percent**  |
| Net revenue: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Automotive | $524.8 | 56.1% | $528.9 | 58.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Industrials | 184.2 | 19.7 | 185.7 | 20.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Aerospace, Defense, and Commercial Equipment | 225.8 | 24.2 | 196.7 | 21.6 |
| Net revenue | 934.8 | 100.0 | 911.3 | 100.0 |
| Operating costs and expenses | 793.2 | 84.8 | 789.1 | 86.6 |
| Operating income | 141.6 | 15.2 | 122.2 | 13.4 |
| Interest expense | (34.1) | (3.6) | (38.0) | (4.2) |
| Interest income | 3.9 | 0.4 | 4.3 | 0.5 |
| Other, net | 4.1 | 0.4 | 2.1 | 0.2 |
| Income before taxes | 115.5 | 12.4 | 90.6 | 9.9 |
| Provision for income taxes | 28.4 | 3.0 | 20.7 | 2.3 |
| Net income | $87.1 | 9.3% | $69.9 | 7.7% |

---

***Net Revenue***

Net revenue for the three months ended March 31, 2026 increased 2.6% compared to the prior period. Net revenue increased 4.2% on an organic basis, which excludes an increase of 2.2% attributed to changes in foreign currency exchange rates and a decrease of 3.8% due primarily to the effects of the divestiture of the Magnetic Speed and Positioning Business ("MSP Business") in the first quarter of 2025. Refer to *Note 16: Disposals* of the Financial Statements, included elsewhere in this Report, for additional information on the sale of the MSP Business.

*Automotive*

Automotive net revenue for the three months ended March 31, 2026 decreased 0.8% compared to the prior period. Excluding an increase of 2.5% attributed to changes in foreign currency exchange and a decrease of 4.0% due to the effects of a divestiture, Automotive net revenue increased 0.7% on an organic basis compared to the prior period, which was primarily due to product mix in the markets we serve.

*Industrials*

Industrials net revenue for the three months ended March 31, 2026 decreased 0.8% compared to the prior period. Excluding an increase of 1.5% attributed to changes in foreign currency exchange and a decrease of 3.0% due to the effect of divestitures, Industrials net revenue grew 0.7% on an organic basis compared to the prior period, which primarily reflects content growth in our Industrials business segment.

*Aerospace, Defense, and Commercial Equipment*

Aerospace, Defense, and Commercial Equipment net revenue for the three months ended March 31, 2026 increased 14.8% compared to the prior period. Excluding an increase of 1.8% attributed to changes in foreign currency exchange rates and a decline of 3.7% due to the effects of a divestiture, Aerospace, Defense, and Commercial Equipment net revenue grew 16.7% on

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

an organic basis due to growth in our commercial equipment and aerospace business.

***Operating Costs and Expenses***

Operating costs and expenses for the three months ended March 31, 2026 and 2025 are presented, in millions of dollars and as a percentage of net revenue, in the following table. Amounts and percentages in the table below have been calculated based on unrounded numbers. Accordingly, certain amounts may not appear to recalculate due to the effect of rounding.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** | **For the three months ended** | **For the three months ended** |
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2025** | **March 31, 2025** |
| | **Amount** | **Percent** | **Amount** | **Percent** |
| Operating costs and expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cost of revenue | $648.5 | 69.4% | $638.7 | 70.1% |
| &nbsp;&nbsp;&nbsp;Research and development | 31.9 | 3.4 | 36.8 | 4.0 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative | 93.4 | 10.0 | 86.0 | 9.4 |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 15.7 | 1.7 | 20.6 | 2.3 |
| &nbsp;&nbsp;&nbsp;Restructuring and other charges, net | 3.7 | 0.4 | 7.0 | 0.8 |
| Total operating costs and expenses | $793.2 | 84.8% | $789.1 | 86.6% |

---

*Cost of revenue*

For the three months ended March 31, 2026, cost of revenue as a percentage of net revenue decreased from the prior period, primarily due to the favorable effects of the MSP divestiture in the first quarter of 2025 and organic revenue growth, partially offset by the net impacts of inflation on material and logistics costs and tariffs.

*Research and development expense*

For the three months ended March 31, 2026, research and development expense did not fluctuate materially from the prior period.

*Selling, general and administrative expense*

For the three months ended March 31, 2026, selling, general and administrative expense did not fluctuate materially from the prior period.

*Amortization of intangible assets*

For the three months ended March 31, 2026, amortization of intangible assets decreased from the prior period, primarily due to the effect of amortization of intangible assets in accordance with their expected economic benefit, which generally results in acceleration of amortization expense in the early years of the life of an intangible asset.

*Restructuring and other charges, net*

In the three months ended March 31, 2026, restructuring and other charges, net decreased from the prior period, primarily due to higher transaction-related charges in 2025 corresponding to the business divestitures that took place in that year, partially offset by higher charges related to the Transformation Plan in the current period.

Refer to *Note 5: Restructuring and Other Charges, Net,* included elsewhere in this Report, for additional information regarding the components of restructuring and other charges, net.

***Operating Income***

For the three months ended March 31, 2026, operating income was $141.6 million, compared to operating income of $122.2 million in the prior period. This favorable impact was driven primarily by (1) higher revenue in the current period, (2) a decrease in amortization of intangibles, and (3) cost savings as a result of actions taken as part of our restructuring plans, partially offset by the net impacts of inflation on material and logistics costs.

***Interest Expense***

For the three months ended March 31, 2026, interest expense did not fluctuate materially from the prior period.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

***Interest Income***

For the three months ended March 31, 2026, interest income did not fluctuate materially from the prior period.

***Other, Net***

Other, net primarily includes gains and losses related to currency remeasurement adjustments, foreign currency and commodity forward contracts not designated as hedging instruments, mark-to-market investments, debt refinancing, and the portion of our net periodic benefit cost excluding service cost.

For the three months ended March 31, 2026, other, net represented a net gain of $4.1 million, a favorable impact on

earnings of $2.0 million compared to a net gain of $2.1 million in the prior period. This favorable impact was primarily due to the absence of losses on forward currency forward contracts in the current year.

Refer to *Note 13: Fair Value Measures* and *Note 6: Other, Net* of the Financial Statements, included elsewhere in this Report, for additional details of our hedge accounting contracts and the components of other, net, respectively.

***Provision for Income Taxes***

The provision for income taxes consists of (1) current tax expense, which relates primarily to our profitable operations in tax jurisdictions with limited or no net operating loss carryforwards and withholding taxes related to management fees, royalties, and the repatriation of foreign earnings; and (2) deferred tax expense (or benefit), which represents adjustments in book-to-tax basis differences primarily related to (a) book versus tax basis in intangible assets, (b) changes in net operating loss carryforwards and tax credits, and (c) changes in withholding taxes on unremitted earnings.

***Non-GAAP Financial Measures***

This section provides additional information regarding certain non-GAAP financial measures, including organic revenue growth (or decline), adjusted operating income, adjusted operating margin, adjusted net income, adjusted earnings per share ("EPS"), free cash flow, adjusted corporate and other expenses, net debt, gross and net leverage ratio, and adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA"), which are used by our management, Board of Directors, and investors. We use these non-GAAP financial measures internally to make operating and strategic decisions, including the preparation of our annual operating plan, evaluation of our overall business performance, and as a factor in determining compensation for certain employees.

The use of our non-GAAP financial measures has limitations. They should be considered as supplemental in nature and are not intended to be considered in isolation from, or as an alternative to, reported net revenue growth (or decline), operating income, operating margin, net income, diluted EPS, net cash provided by operating activities, corporate and other expenses, or total debt and finance lease obligations, respectively, calculated in accordance with U.S. GAAP. In addition, our measures of organic revenue growth (or decline), adjusted operating income, adjusted operating margin, adjusted net income, adjusted EPS, free cash flow, adjusted corporate and other expenses, gross and net leverage ratio, and adjusted EBITDA may not be the same as, or comparable to, similar non-GAAP financial measures presented by other companies.

***Organic revenue growth (or decline) and market outgrowth***

Organic revenue growth (or decline) is defined as the reported percentage change in net revenue calculated in accordance with U.S. GAAP, excluding the period-over-period impact of foreign exchange rate differences as well as the net impact of material acquisitions, divestitures, and product life-cycle management actions for the 12-month period following the respective transaction date(s).

We believe that organic revenue growth (or decline) provides investors with helpful information with respect to our operating performance, and we use organic revenue growth (or decline) to evaluate our ongoing operations as well as for internal planning and forecasting purposes. We believe that organic revenue growth (or decline) provides useful information in evaluating the results of our business because it excludes items that we believe are not indicative of ongoing performance or that we believe impact comparability with the prior period.

Market outgrowth is calculated as organic revenue growth less our weighted market growth. Our weighted market growth is calculated using our regional and platform sales mix, as applicable, in the corresponding prior period. Market outgrowth is used to describe the impact of an increasing quantity and value of our products used in customer systems and applications above market growth. We believe this provides a more meaningful comparison of our revenue growth relative to the markets we serve.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

***Adjusted operating income, adjusted operating margin, adjusted net income, and adjusted EPS***

We define adjusted operating income as operating income (or loss), determined in accordance with U.S. GAAP, adjusted to exclude certain non-GAAP adjustments which are described under the heading *Non-GAAP Adjustments* below. Adjusted operating margin is calculated by dividing adjusted operating income (or loss) by net revenue determined in accordance with U.S. GAAP. We define adjusted net income as follows: net income (or loss) determined in accordance with U.S. GAAP, excluding certain non-GAAP adjustments which are described under the heading *Non-GAAP Adjustments* below. Adjusted EPS is calculated by dividing adjusted net income by the number of diluted weighted-average ordinary shares outstanding in the period as determined in accordance with U.S. GAAP.

Management uses adjusted operating income, adjusted operating margin, adjusted net income, and adjusted EPS (and the constant currency equivalent of each) as measures of operating performance, for planning purposes (including the preparation of our annual operating budget), to allocate resources to enhance the financial performance of our business, to evaluate the effectiveness of our business strategies, in communications with our Board of Directors and investors concerning our financial performance, and as factors in determining compensation for certain employees. We believe investors and securities analysts also use these non-GAAP financial measures in their evaluation of our performance and the performance of other similar companies. These non-GAAP financial measures are not measures of liquidity.

***Free cash flow***

Free cash flow is defined as net cash provided by operating activities less additions to property, plant and equipment and capitalized software. Free cash flow conversion is defined as Free cash flow divided by Adjusted net income. We believe free cash flow is useful to management and investors as a measure of cash generated by business operations that will be used to repay scheduled debt maturities and can be used to, among other things, fund acquisitions, repurchase ordinary shares, or accelerate the repayment of debt obligations.

***Adjusted corporate and other expenses***

Adjusted corporate and other expenses is defined as corporate and other expenses calculated in accordance with U.S. GAAP, excluding the portion of non-GAAP adjustments described below that relate to corporate and other expenses. We believe adjusted corporate and other expenses is useful to management and investors in understanding the impact of non-GAAP adjustments on operating expenses not allocated to our segments.

***Adjusted EBITDA***

Adjusted EBITDA is defined as net income (or loss), determined in accordance with U.S. GAAP, excluding interest expense, interest income, and provision for (or benefit from) income taxes, depreciation expense, amortization of intangible assets, and the following non-GAAP adjustments, if applicable: (1) restructuring related and other, (2) financing and other transaction costs, and (3) other, net. Refer to *Non-GAAP Adjustments* below for additional discussion of these adjustments.

***Gross leverage ratio***

Gross leverage ratio represents gross debt (total debt and finance lease obligations less unamortized issue costs) divided by last twelve months ("LTM") adjusted EBITDA. We believe that gross leverage ratio is a useful measure to management and investors in understanding trends in our overall financial condition.

***Net leverage ratio***

Net leverage ratio represents net debt (gross debt less cash and cash equivalents) divided by LTM adjusted EBITDA. We believe that the net leverage ratio is a useful measure to management and investors in understanding trends in our overall financial condition.

***Non-GAAP adjustments***

Many of our non-GAAP adjustments relate to a series of strategic initiatives developed by our management aimed at better positioning us for future revenue growth and an improved cost structure. These initiatives have been modified from time to time to reflect changes in overall market conditions and the competitive environment facing our business. These initiatives include, among other items, acquisitions, divestitures, restructurings of certain business, supply chain or corporate activities, and various financing transactions. We describe these adjustments in more detail below, each of which is net of current tax impacts, as applicable.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Restructuring related and other*: includes net charges related to certain restructuring and other exit activities, other costs (or income) that we believe are either unique or unusual to the identified reporting period, and the impact of commodity forward contracts that we believe impact comparisons to prior period operating results. Such costs include charges related to optimization of our manufacturing processes to increase productivity. This type of activity occurs periodically; however, each action is unique, discrete, and driven by various facts and circumstances. Such amounts are excluded from internal financial statements and analyses that management uses in connection with financial planning and in its review and assessment of our operating and financial performance, including the performance of our segments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Financing and other transaction costs*: includes costs incurred, such as legal, accounting, and other professional services, that are directly related to an acquisition, divestiture, or equity financing transaction, expenses related to compensation arrangements entered into concurrent with the closing of an acquisition, adjustments related to changes in the fair value of acquisition-related contingent consideration amounts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Amortization of intangible assets*: represents amortization of intangible assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Other, net:* includes non-operating expenses (or non-operating income) recorded within Other, net on our condensed consolidated statements of operations. Refer to *Note 6: Other, Net* of the Financial Statements, included elsewhere in this Quarterly Report, for additional details of the components of Other, net.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Deferred taxes and other tax related*: includes adjustments for deferred taxes and other timing differences including, but not limited to, book-to-tax basis differences on the fair value of intangible assets and goodwill, the utilization of net operating losses, and adjustments to our valuation allowance in connection with certain transactions and tax law changes. Other tax related items include certain adjustments to unrecognized tax benefits and withholding tax on repatriation of foreign earnings.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Amortization of debt issuance costs:* represents interest expense related to the amortization of deferred financing costs as well as debt discounts, net of premiums.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Where applicable, the current income tax effect of non-GAAP adjustments.

Our definition of adjusted net income excludes the deferred provision for (or benefit from) income taxes and other tax related items described above. As we treat deferred income taxes as an adjustment to compute adjusted net income, the deferred income tax effect associated with the reconciling items presented below would not change adjusted net income for any period presented.

***Non-GAAP reconciliations***

The following tables present reconciliations of certain financial measures calculated in accordance with U.S. GAAP to the related non-GAAP financial measures for the three months ended March 31, 2026 and 2025. Refer to the *Non-GAAP Adjustments* section above for additional information regarding these adjustments. Amounts and percentages in the tables below have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the three months ended March 31, 2026** | **For the three months ended March 31, 2026** | **For the three months ended March 31, 2026** | **For the three months ended March 31, 2026** | **For the three months ended March 31, 2026** |
| *(Dollars in millions, except per share amounts)* | **Operating Income** | **Operating Margin** | **Income Taxes** | **Net Income** | **Diluted EPS** |
| Reported (GAAP) | $141.6 | 15.2% | $28.4 | $87.1 | $0.59 |
| Non-GAAP adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring related and other <sup>(a)</sup> | 16.6 | 1.8 | (1.7) | 14.9 | 0.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing and other transaction costs <sup>(b)</sup> | 0.1 |  |  | 0.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets  | 15.7 | 1.7 |  | 15.7 | 0.11 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs |  |  |  | 1.1 | 0.01 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net |  |  | 0.8 | (3.3) | (0.02) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred taxes and other tax related  |  |  | 9.9 | 9.9 | 0.07 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total adjustments | 32.4 | 3.5 | 9.0 | 38.4 | 0.26 |
| Adjusted (non-GAAP) | $174.0 | 18.6% | $19.4 | $125.5 | $0.86 |

---

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** | **For the three months ended March 31, 2025** |
| *(Dollars in millions, except per share amounts)* | **Operating Income** | **Operating Margin** | **Income Taxes** | **Net Income** | **Diluted EPS** |
| Reported (GAAP) | $122.2 | 13.4% | $20.7 | $69.9 | $0.47 |
| Non-GAAP adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring related and other <sup>(a)</sup> | 18.3 | 2.0 | 1.6 | 19.9 | 0.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing and other transaction costs <sup>(b)</sup> | 5.4 | 0.6 |  | 5.4 | 0.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets  | 20.6 | 2.3 |  | 20.6 | 0.14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs |  |  |  | 1.2 | 0.01 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net |  |  | (0.5) | (2.6) | (0.02) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred taxes and other tax related |  |  | 2.2 | 2.2 | 0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total adjustments | 44.3 | 4.9 | 3.3 | 46.7 | 0.31 |
| Adjusted (non-GAAP) | $166.5 | 18.3% | $17.4 | $116.6 | $0.78 |

---

<sup>(a)</sup>&nbsp;&nbsp;&nbsp;&nbsp;The following table presents the components of our restructuring related and other non-GAAP adjustment to net income for the three months ended March 31, 2026 and 2025 (amounts have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding):

---

| | | |
|:---|:---|:---|
| | **For the three months ended March 31,** | **For the three months ended March 31,** |
| *(In millions)* | **2026** | **2025** |
| Business and corporate repositioning <sup>(i)</sup> | $13.9 | $18.1 |
| Other  | 2.7 | 0.2 |
| Income tax effect | (1.7) | 1.6 |
| Total non-GAAP restructuring related and other | $14.9 | $19.9 |

---

__________________________

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.Primarily includes charges related to repositioning our business and corporate functions to more effectively respond to the challenges that face the business, including severance, contract termination costs, charges related to asset write-downs, and other various restructuring-related charges.

<sup>(b)</sup>&nbsp;&nbsp;&nbsp;&nbsp;The following table presents the components of our financing and other transaction costs non-GAAP adjustment to net income for the three months ended March 31, 2026 and 2025 (amounts have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding):

---

| | | |
|:---|:---|:---|
| | **For the three months ended March 31,** | **For the three months ended March 31,** |
| *(In millions)* | **2026** | **2025** |
| Transaction loss <sup>(i)</sup> | $— | $4.7 |
| Merger and acquisition compensation arrangements <sup>(ii)</sup> | (0.4) | 0.7 |
| Other | 0.4 |  |
| Income tax effect |  |  |
| Total financing and other transaction costs | $0.1 | $5.4 |

---

__________________________

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.Primarily includes losses or gains related to the divestiture of a business, costs incurred, including for legal, accounting, and other professional services, that are directly related to an acquisition, divestiture, or other transaction. In the three months ended March 31, 2025, this line includes costs and losses associated with the disposition of the MSP Business. Refer to *Note 16: Disposals* for further information on this transaction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.Primarily relates to compensation arrangements entered into concurrent with the closing of an acquisition and compensation in connection with the closing of a transaction.

The following table provides a reconciliation of net cash provided by operating activities in accordance with U.S. GAAP to free cash flow.

---

| | | |
|:---|:---|:---|
| | **For the three months ended March 31,** | **For the three months ended March 31,** |
| *(In millions)* | **2026** | **2025** |
| Net cash provided by operating activities (GAAP) | $122.5 | $119.2 |
| Additions to property, plant and equipment and capitalized software | (17.9) | (32.6) |
| Free cash flow (non-GAAP) | $104.6 | $86.6 |

---

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

The following table provides a reconciliation of corporate and other expenses in accordance with U.S. GAAP to adjusted corporate and other expenses.

---

| | | |
|:---|:---|:---|
| | **For the three months ended March 31,** | **For the three months ended March 31,** |
| *(In millions)* | **2026** | **2025** |
| Corporate and other expenses (GAAP) | $(75.7) | $(69.2) |
| Restructuring related and other | 12.9 | 15.8 |
| Financing and other transaction costs | 0.1 | 1.0 |
| Total adjustments | 13.0 | 16.8 |
| Adjusted corporate and other expenses (non-GAAP) | $(62.7) | $(52.4) |

---

The following table provides a reconciliation of net income in accordance with U.S. GAAP to adjusted EBITDA.

---

| | | | |
|:---|:---|:---|:---|
| | | **For the three months ended March 31,** | **For the three months ended March 31,** |
| *(In millions)* | **LTM** | **2026** | **2025** |
| Net income | $48.5 | $87.1 | $69.9 |
| Interest expense, net | 126.5 | 30.2 | 33.7 |
| Provision for income taxes | 99.7 | 28.4 | 20.7 |
| Depreciation expense | 169.3 | 34.0 | 41.0 |
| Amortization of intangible assets | 75.4 | 15.7 | 20.6 |
| EBITDA | 519.4 | 195.5 | 185.9 |
| Non-GAAP adjustments |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring related and other | 311.0 | 15.0 | 11.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing and other transaction costs | 29.6 | 0.1 | 5.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | (17.8) | (4.1) | (2.1) |
| Adjusted EBITDA | $842.2 | $206.5 | $200.2 |

---

The following table provides a reconciliation of total debt and finance lease obligations in accordance with U.S. GAAP to gross and net debt balances and leverage ratios.

---

| | | |
|:---|:---|:---|
| *(Dollars in millions)* | **March 31,<br>2026** | **December 31,<br>2025** |
| Current portion of long-term debt and finance lease obligations | $2.4 | $2.3 |
| Finance lease obligations, less current portion | 18.5 | 18.9 |
| Long-term debt, net | 2829.4 | 2828.6 |
| Total debt and finance lease obligations | 2850.2 | 2849.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: debt premium, net | 0.4 | 0.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: deferred financing costs | (17.1) | (17.9) |
| Total gross indebtedness | $2866.9 | $2867.2 |
| Adjusted EBITDA (LTM) | $842.2 | $835.9 |
| Gross leverage ratio | 3.4 | 3.4 |
| Total gross indebtedness | $2866.9 | $2867.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: cash and cash equivalents | 635.1 | 573.0 |
| Net debt | $2231.8 | $2294.2 |
| Adjusted EBITDA (LTM) | $842.2 | $835.9 |
| Net leverage ratio | 2.6 | 2.7 |

---

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

***Liquidity and Capital Resources***

As of March 31, 2026 and December 31, 2025, we held cash and cash equivalents in the following regions (amounts have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding):

---

| | | |
|:---|:---|:---|
| *(In millions)* | **March 31,<br>2026** | **December 31,<br>2025** |
| United Kingdom | $4.2 | $3.6 |
| United States | 8.8 | 8.0 |
| The Netherlands | 432.4 | 421.8 |
| China | 125.6 | 80.7 |
| Other | 64.1 | 58.9 |
| Total | $635.1 | $573.0 |

---

The amount of cash and cash equivalents held in these geographic regions fluctuates throughout the year due to a variety of factors, such as our use of intercompany loans and dividends and the timing of cash receipts and disbursements in the normal course of business. Our earnings are not considered to be permanently reinvested in certain jurisdictions in which they were earned. We recognize a deferred tax liability on these unremitted earnings to the extent the remittance of such earnings cannot be recovered in a tax-free manner.

In certain jurisdictions, our cash balances are subject to withholding taxes immediately upon withdrawal of funds to a different jurisdiction. In addition, in order to take advantage of incentive programs offered by various jurisdictions, including tax incentives, we are required to maintain minimum cash balances in these jurisdictions. The transfer of cash from these jurisdictions could result in loss of incentives or higher cash tax expense, but those impacts are not expected to be material.

Our cash and cash equivalents balances are held in the following significant currencies (amounts in the tables below have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** |
| *(In millions)* | **United States Dollar ("USD")** | **Euro ("EUR")** | **British Pound Sterling ("GBP")** | **Chinese Renminbi ("CNY")** | **Other** |
| United Kingdom | $— | 0.0 | £2.5 | ¥— |  |
| United States | 8.7 | 0.1 |  |  |  |
| The Netherlands | 422.7 | 8.1 | 0.3 |  |  |
| China | 31.4 |  |  | 651.1 |  |
| Other | 43.7 | 6.5 |  |  |  |
| Total | $506.5 | 14.7 | £2.8 | ¥651.1 |  |
| USD Equivalent |  | $16.9 | $3.7 | $94.2 | $13.8 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** |
| *(In millions)* | **USD** | **EUR** | **GBP** | **CNY** | **Other** |
| United Kingdom | $— | 0.0 | £2.6 | ¥— |  |
| United States | 8.0 | 0.0 | 0.0 |  |  |
| The Netherlands | 411.4 | 8.2 | 0.6 |  |  |
| China | 20.1 |  |  | 423.3 |  |
| Other | 43.8 | 1.9 |  |  |  |
| Total | $483.3 | 10.1 | £3.2 | ¥423.3 |  |
| USD Equivalent |  | $11.9 | $4.3 | $60.5 | $13.0 |

---

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

*Cash Flows:*

The table below summarizes our primary sources and uses of cash for the three months ended March 31, 2026 and 2025. We have derived these summarized statements of cash flows from the Financial Statements included elsewhere in this Report. Amounts in the table below have been calculated based on unrounded numbers. Accordingly, certain amounts may not appear to recalculate due to the effect of rounding.

---

| | | |
|:---|:---|:---|
| | **For the three months ended** | **For the three months ended** |
| *(In millions)* | **March 31, 2026** | **March 31, 2025** |
| Net cash provided by/(used in): |  |  |
| Operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income adjusted for non-cash items | $156.6 | $141.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities, net | (34.1) | (22.7) |
| Operating activities | 122.5 | 119.2 |
| Investing activities | (16.5) | (6.9) |
| Financing activities | (44.7) | (119.1) |
| Effects of exchange rate differences | 0.8 | 1.3 |
| Net change | $62.1 | $(5.5) |

---

*Operating activities.* Net cash provided by operating activities for the three months ended March 31, 2026 increased compared to the corresponding period of the prior year, primarily due to higher cash provided by earnings, partially offset by unfavorable changes in working capital.

*Investing activities.* Net cash used in investing activities for the three months ended March 31, 2026 was $16.5 million compared to cash used of $6.9 million for the corresponding period of the prior year. This change was primarily due to proceeds received for the sale of the MSP Business in the first quarter of 2025, partially offset by higher capital expenditures in the prior period. For fiscal year 2026, we anticipate additions to PP&E and capitalized software of up to approximately $150.0 million, which we expect to fund with cash flows from operations.

*Financing activities*. Net cash used in financing activities for the three months ended March 31, 2026 was $44.7 million compared to cash used in financing activities of $119.1 million in the corresponding period of the prior year. This change was primarily due to a higher amount of cash paid to repurchase ordinary shares in the prior year.

*Indebtedness and Liquidity*

As of March 31, 2026, we had $2.9 billion in gross indebtedness, which includes finance lease obligations and excludes debt discounts, premiums, and deferred financing costs.

***Capital Resources***

*Sources of liquidity*

Our sources of liquidity include cash on hand, cash flows from operations, and available capacity under the Revolving Credit Facility. As of March 31, 2026, we had $645.8 million available under the Revolving Credit Facility, net of $4.2 million of obligations in respect of outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of March 31, 2026, no amounts had been drawn against these outstanding letters of credit. This Revolving Credit Facility includes an accordion feature under which maximum borrowings may be increased under certain circumstances.

We believe, based on our current level of operations and taking into consideration the restrictions and covenants included in the Credit Agreement, Revolving Credit Facility, and Senior Notes Indentures, that the sources of liquidity described above will be sufficient to fund our operations, capital expenditures, dividend payments, ordinary share repurchases, and debt service for at least the next twelve months. However, we cannot make assurances that our business will generate sufficient cash flows from operations or that future borrowings will be available to us in an amount sufficient to enable us to pay our indebtedness or to fund our other liquidity needs. Further, the amount of our debt may limit our ability to procure additional financing in the future.

Our ability to raise additional financing, and our borrowing costs, may be impacted by short- and long-term debt ratings assigned by independent rating agencies, which are based, in significant part, on our performance as measured by certain credit

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

metrics such as interest coverage and leverage ratios. As of April 16, 2026, Moody's Investors Service's corporate credit rating for STBV was Ba2 with a stable outlook, and Standard & Poor's corporate credit rating for STBV was BB+ with a stable outlook. Any future downgrades to STBV's credit ratings may increase our future borrowing costs but will not reduce availability under the Credit Agreement.

*Restrictions and Covenants*

The Credit Agreement provides that if our senior secured net leverage ratio exceeds a specified level, we are required to use a portion of our excess cash flow, as defined in the Credit Agreement, generated by operating, investing, or financing activities to prepay some or all of the outstanding borrowings under the Senior Secured Credit Facilities. The Credit Agreement also requires mandatory prepayments of the outstanding borrowings under the Senior Secured Credit Facilities upon certain asset dispositions and casualty events, in each case subject to certain reinvestment rights, and upon the incurrence of certain indebtedness (excluding any permitted indebtedness). These provisions were not triggered during the three months ended March 31, 2026.

The Credit Agreement and the Senior Notes Indentures contain restrictions and covenants that limit the ability of our wholly-owned subsidiary, STBV, and certain of its subsidiaries to, among other things, incur subsequent indebtedness, sell assets, pay dividends, and make other restricted payments. For a full discussion of these restrictions and covenants, refer to *Part II, Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations—Capital Resources* included in our 2025 Annual Report. These restrictions and covenants, which are subject to important exceptions and qualifications set forth in the Credit Agreement and Senior Notes Indentures, were taken into consideration when we established our share repurchase programs and will be evaluated periodically with respect to future potential funding of those programs. As of March 31, 2026, we believe we were in compliance with all covenants and default provisions under our credit arrangements.

*Share repurchase programs*

From time to time, our Board of Directors has authorized various share repurchase programs, which may be modified or terminated by our Board at any time. We currently have authorization for the September 2023 Program, under which approximately $257.3 million remained available as of March 31, 2026. In the three months ended March 31, 2026, and 2025, we repurchased 0.7 million and 3.5 million ordinary shares under the September 2023 Program.

*Dividends*

In the three months ended March 31, 2026 and 2025, we paid aggregate cash dividends of $17.5 million and $17.9 million, respectively. In April 2026, we announced that our Board of Directors approved a quarterly dividend of $0.12 per share, payable in May 2026 to shareholders of record as of May 13, 2026.

***Critical Accounting Policies and Estimates***

For a discussion of the critical accounting policies that require the use of significant judgments and estimates by management, refer to *Part II, Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates* included in our 2025 Annual Report. The preparation of consolidated financial statements in accordance with U.S. GAAP requires us to exercise judgment in the process of applying our accounting policies. It also requires that we make estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements and accompanying notes. No material changes to our critical accounting policies and estimates, as previously disclosed, have occurred during the first three months of 2026.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

No significant changes to our market risk have occurred since December 31, 2025. For a discussion of market risks affecting us, refer to *Part II, Item 7A: Quantitative and Qualitative Disclosures About Market Risk* included in our 2025 Annual Report.

**Item 4. Controls and Procedures.**

The required certifications of our Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer are included as exhibits to this Quarterly Report on Form 10-Q. The disclosures set forth in this Item 4 contain information concerning the evaluation of our disclosure controls and procedures and changes in internal control over financial reporting referred to in these certifications. These certifications should be read in conjunction with this Item 4 for a more complete understanding of the matters covered by the certifications.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

***Evaluation of Disclosure Controls and Procedures***

With the participation of our Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer, we have evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2026. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the U.S. Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March 31, 2026, our Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

***Changes in Internal Control over Financial Reporting***

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the three months ended March 31, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

***Inherent Limitations on Effectiveness of Controls***

There are inherent limitations to the effectiveness of any system of internal control over financial reporting. Accordingly, even an effective system of internal control over financial reporting can only provide reasonable assurance with respect to financial statement preparation and presentation in accordance with U.S. GAAP. Our internal controls over financial reporting are subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may be inadequate because of changes in conditions and the risk that the degree of compliance with policies or procedures may deteriorate over time.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**PART II—OTHER INFORMATION**

**Item 1. Legal Proceedings.**

We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial condition, and/or cash flows.

**Item 1A. Risk Factors.**

Information regarding risk factors appears in *Part I, Item 1A: Risk Factors*, included in our 2025 Annual Report. There have been no material changes to the risk factors disclosed therein.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.** 

***Issuer Purchases of Equity Securities***

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Shares Purchased (in shares)** <sup>(1)</sup> | **Weighted-Average Price Paid per Share** | **Total Number of Shares Purchased as Part of Publicly Announced Plan or Programs** | **Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan or Programs <br>(in millions)** |
| January 1 through January 31, 2026 | 42641 | $34.16 |  | $282.4 |
| February 1 through February 28, 2026 | 246822 | $37.93 | 244440 | $273.1 |
| March 1 through March 31, 2026 | 453598 | $35.04 | 452495 | $257.3 |
| Quarter total | 743061 | $35.95 | 696935 | $257.3 |

---

___________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The total number of ordinary shares purchased includes ordinary shares that were withheld upon the vesting of restricted securities to cover payment of employee withholding tax. These withholdings took place outside of a publicly announced repurchase plan. There were 42,641, 2,382, and 1,103 ordinary shares withheld in January 2026, February 2026, and March 2026, respectively, representing a total aggregate fair value of $1.6 million based on the closing price of our ordinary shares on the date of withholdings.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 5. Other Information**

During the three months ended March 31, 2026, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**Item 6. Exhibits.**

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| 3.1 | <u>[Articles of Association of Sensata Technologies Holding plc (incorporated by reference to Exhibit 3.1 of the Registrant's Current Report on Form 8-K filed on March 28, 2018).](https://www.sec.gov/Archives/edgar/data/1477294/000147729418000050/articlesofassociation-sthp.htm)</u> |
| 10.1 | <u>[Technical Amendment to Credit Agreement, dated as of April](technicalamendmenttocredit.htm)[13](technicalamendmenttocredit.htm)[, 2026, by and among Sensata Technologies, Inc., Sensata Technologies Intermediate Holding B.V., Sensata Technologies B.V., the other Guarantors party thereto, Morgan Stanley Senior Funding, Inc., as the Administrative Agent, an L/C Issuer and the Swing Line Lender, and the Revolving Credit Lenders and other L/C Issuers party thereto .\*](technicalamendmenttocredit.htm)</u> |
| 10.2 | <u>[Form of Award Agreement for Restricted Stock Units under the Sensata Technologies Holding plc 2021 Equity Incentive Plan.\*†](a2026rsuagreement.htm)</u> |
| 10.3 | <u>[Form of Award Agreement for Performance Restricted Stock Units under the Sensata Technologies Holding plc 2021 Equity Incentive Plan .](a2026prsuagreement.htm)[\*†](a2026prsuagreement.htm)</u> |
| 31.1 | <u>[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\*](exhibit311_03312026.htm)</u> |
| 31.2 | <u>[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\*](exhibit312_03312026.htm)</u>  |
| 31.3 | <u>[Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.\*](exhibit313_03312026.htm)</u> |
| 32.1 | <u>[Certification of Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.\*](exhibit321_03312026.htm)</u> |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. \* |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. \* |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. \* |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. \* |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. \* |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |

---

___________________________________

\*&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith

†&nbsp;&nbsp;&nbsp;&nbsp;Indicates management contract or compensatory plan, contract or arrangement.

------

**<u>[**Table of Contents**](#i999f43933e1c498f83f7dc56fc492f04_7)</u>**

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: April 28, 2026

---

| |
|:---|
| SENSATA TECHNOLOGIES HOLDING PLC |
| /s/ Stephan von Schuckmann |
| **(Stephan von Schuckmann)**<br>***Chief Executive Officer***<br>***(Principal Executive Officer)*** |
| /s/ Andrew Lynch |
| **(Andrew Lynch)**<br>***Executive Vice President and Chief Financial Officer***<br>***(Principal Financial Officer)*** |
| /s/ Richard Siedel |
| **(Richard Siedel)**<br>***Senior Vice President and Chief Accounting Officer***<br>***(Principal Accounting Officer)*** |

---

## Exhibit 10.1

***Execution Version***

**TECHNICAL AMENDMENT TO CREDIT AGREEMENT** 

TECHNICAL AMENDMENT TO CREDIT AGREEMENT dated as of April 13, 2026 (this "<u>Amendment</u>"), is entered into by and among, SENSATA TECHNOLOGIES, INC., a Delaware corporation (the "<u>Borrower</u>"), MORGAN STANLEY SENIOR FUNDING, INC. as administrative agent on behalf of the lenders party to the Credit Agreement (as defined below) (in such capacity, the "<u>Administrative Agent</u>").

**PRELIMINARY STATEMENTS:**

WHEREAS, the Borrower, Sensata Technologies Intermediate Holding B.V., the Administrative Agent and certain lenders are parties to that certain Credit Agreement, dated as of May 12, 2011, as amended, restated, amended and restated, supplemented, waived or otherwise modified prior to the date hereof (as so amended, restated, amended and restated, supplemented, waived or otherwise modified, the "<u>Credit Agreement</u>"; capitalized terms used but not otherwise defined in this Amendment have the same meanings as specified in the Credit Agreement);

WHEREAS, Section 10.01 of the Credit Agreement provides that:

"…if at any time after the Closing Date, the Administrative Agent and the Borrower shall have jointly identified an obvious error or any error or omission of a technical or immaterial nature, in each case, in any provision of the Loan Documents, then the Administrative Agent and the Borrower shall be permitted to amend such provision and such amendment shall become effective without any further action or consent of any other party to any Loan Document if the same is not objected to in writing by the Required Lenders within five (5) Business Days following receipt of notice thereof."

WHEREAS, the Administrative Agent and the Borrower have jointly identified certain errors and omissions in the Credit Agreement;

WHEREAS, the Administrative Agent and the Borrower desire to amend the Credit Agreement in reliance on the portion of Section 10.01 quoted above to correct such errors and omissions; and

WHEREAS, the Administrative Agent provided to the Lenders a copy of certain proposed amendments to the Credit Agreement to correct such errors and omissions, which proposed amendments are set forth in Section 1 hereof, and such amendments were not objected to in writing by the Required Lenders within five (5) Business Days following receipt of notice thereof;

NOW, THEREFORE, in reliance on the portion of Section 10.01 of the Credit Agreement quoted above, the parties hereto hereby agree as follows:

AMER_SHEARMAN/2050060393.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Technical Amendment to<br>Credit Agreement

FH13379403.2

------

SECTION 1.<u>Amendments to Credit Agreement</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Effective as of the date hereof, the definition of "Secured Hedge Agreement" in the Credit Agreement is hereby amended and restated in its entirety to effect the changes that are shown in blackline form below (with bolded and underlined text representing additions and strikethroughs representing deletions):

"**Secured Hedge Agreement**" means any Swap Contract permitted under Article 7 that is entered into by and between any**<u>STBV, the</u>** Borrower or **<u>any</u>** Restricted Subsidiary and any Hedge Bank and designated in writing by the Hedge Bank and such**<u>STBV, the</u>** Borrower or **<u>such</u>** Restricted Subsidiary (as applicable) to the Administrative Agent as a "Secured Hedge Agreement."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Effective as of the date hereof, the definition of "Cash Management Obligations" in the Credit Agreement is hereby amended and restated in its entirety to effect the changes that are shown in blackline form below (with bolded and underlined text representing additions and strikethroughs representing deletions):

"**Cash Management Obligations**" means obligations owed by **<u>STBV, the</u>** Borrower or any other Subsidiary of STBV to any Lender or any Affiliate of a Lender in respect of any overdraft and related liabilities arising from treasury, depository and cash management services or any automated clearing house transfers of funds or in respect of any credit card or similar services designated by **<u>STBV,</u>** the Borrower **<u>or such Restricted Subsidiary</u>** (as applicable) as constituting Cash Management Obligations.

SECTION 2.<u>Reference to and Effect on the Loan Documents</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)On and after the date hereof, each reference in the Credit Agreement to "this Agreement", "hereunder", "hereof" or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to the "Credit Agreement", "thereunder", "thereof" or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement, as amended by this Amendment. For the avoidance of doubt, this Amendment shall also constitute a Loan Document under the Credit Agreement, as amended by this Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Credit Agreement and the other Loan Documents, as specifically amended or otherwise modified (or contemplated to be amended or otherwise modified) by this Amendment, are, and shall continue to be, in full force and effect, and are hereby in all respects ratified and confirmed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Except as expressly provided herein, the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under the Credit Agreement or any other Loan Document, nor shall it constitute a waiver of any provision of the Credit Agreement or any other Loan Document.

AMER_SHEARMAN/2050060393.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Technical Amendment to<br>Credit Agreement

FH13379403.2

------

SECTION 3.<u>Conditions of Effectiveness for Amendment</u>. This Amendment shall become effective as of the date the Administrative Agent shall have received counterparts of this Amendment executed by the Borrower and the Administrative Agent.

SECTION 4.<u>Execution in Counterparts</u>. This Amendment may be executed in one or more counterparts (and by different parties hereto in different counterparts), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery by telecopier or other electronic transmission of an executed counterpart of a signature page to this Amendment, including by email with a pdf copy hereof attached, shall be effective as delivery of an original executed counterpart of this Amendment. The words "execution", "signed", "signature", "delivery" and words of like import in or relating to this Amendment shall be deemed to include Electronic Signatures, deliveries or the keeping of records in any electronic form (including deliveries by emailed pdf or any other electronic means that reproduces an image of an actual executed signature page), each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. As used herein, "<u>Electronic Signature</u>" shall mean an electronic sound, symbol or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record.

SECTION 5.<u>Governing Law and Waiver of Right of Trial by Jury</u>. This Amendment is subject to the provisions of <u>Sections 10.17</u> and <u>10.18</u> of the Credit Agreement relating to governing law, waiver of right to submission to jurisdiction, venue and waiver of trial by jury, the provisions which are by this reference incorporated herein in full.

SECTION 6.<u>Continuing Obligations</u>. The Obligations existing immediately prior to this Amendment shall, to the extent outstanding immediately following this Amendment, comprise Obligations under the Credit Agreement as amended by this Amendment and each other Loan Document, and neither this Amendment nor the transactions contemplated in connection herewith shall constitute a novation or termination of such Obligations, and the Collateral, shall continue to secure, support and otherwise benefit the Obligations of the Loan Parties under the Credit Agreement as amended by this Amendment and each other Loan Document.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

AMER_SHEARMAN/2050060393.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Technical Amendment to<br>Credit Agreement

FH13379403.2

------

**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF**, the parties have caused this Technical Amendment to Credit Agreement to be executed by their respective authorized officers as of the date first above written.

**SENSATA TECHNOLOGIES, INC.,** as <br>the Borrower<br>

By: ____<u>/s/ Frank E. DeVita</u>_________________<br>Name: Frank E. DeVita &nbsp;&nbsp;&nbsp;&nbsp;<br>Title: Treasurer

[Sensata – Technical Amendment to Credit Agreement]

FH13379403.2

------

**MORGAN STANLEY SENIOR FUNDING, INC.**, as Administrative Agent

**<br>**

<br> By: ___<u>/s/ Jennifer DeFazio</u>_____________<br> Name: Jennifer DeFazio&nbsp;&nbsp;&nbsp;&nbsp;<br>Title: Authorized Signatory

[Sensata – Technical Amendment to Credit Agreement]

FH13379403.2

## Exhibit 10.2

AWARD AGREEMENT

SENSATA TECHNOLOGIES HOLDING PLC<br>(the "<u>Company</u>")

**RESTRICTED STOCK UNITS**

Date: %%OPTION_DATE,'Month DD, YYYY'%-% ("<u>Grant Date</u>")

Issue to:

%%FIRST_NAME%-% %%LAST_NAME%-% ("<u>Participant</u>")

%%TOTAL_SHARES_GRANTED,'999,999,999'%-% Restricted Stock Units of the Company (the "<u>Units</u>"). Each Unit represents the right to receive one Ordinary Share, par value €0.01 per Ordinary Share.

The Units are "Restricted Stock Units" as such term is defined in the Company's 2021 Equity Incentive Plan, as may be amended from time to time (the "<u>Plan</u>"), and such Units are subject to all of the terms and conditions set forth below and in the Plan in effect from time to time. Any capitalized term used herein and not otherwise defined shall have the meaning ascribed to such term in the Plan. For valuable consideration, receipt of which is acknowledged, Participant agrees to the following additional terms and conditions.

**Unit Terms and Conditions**

1.<u>Plan Incorporated by Reference</u>. This Award Agreement (this "<u>Agreement</u>") is subject to the terms of the Plan and may be amended as provided in the Plan. This Award Agreement does not set forth all of the terms and conditions of the Plan, which are incorporated herein by reference. The Committee administers the Plan and its determinations regarding the operation of the Plan are final and binding. Copies of the Plan may be obtained upon written request without charge from the Legal Department of the Company.

2.<u>Restricted Stock Unit</u>. Each Unit represents the right to receive one Ordinary Share, subject to the fulfillment of the vesting conditions.

3.<u>Vesting of Units; Issuance of Ordinary Shares</u>. Subject to Section 4 below, the Units shall vest in three equal installments on the first, second, and third anniversary of the Grant Date as follows (each a "<u>Vesting Date</u>").

---

| | |
|:---|:---|
| <u>Vesting Dates</u> | <u>Cumulative Percentage of Units Vested</u> |
| %%VEST_DATE_PERIOD1,'Month DD, YYYY'%-%%%VEST_DATE_PERIOD2,'Month DD, YYYY'%-%%%VEST_DATE_PERIOD3,'Month DD, YYYY'%-% | 1/3 or 33.3%<br>1/3 or 33.3%<br>1/3 or 33.4% |

---

4.<u>Vesting on Termination of Employment, Death, Disability, Retirement and Change in Control.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.<u>General</u>. Unless otherwise provided in this Section 4, any unvested Units shall be forfeited immediately upon the date that Participant terminates his or her service with the Company or any Subsidiary or Affiliate or otherwise ceases to be an Eligible Person (each referred to as the

 <br> <br>

------

"<u>Termination Date</u>"). Unless otherwise expressly provided in this Agreement or determined by the Committee or its designee, Participant's right to vest in the Units under the Plan, if any, will terminate as of such Termination Date and will not be extended by any notice period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.<u>Participant's Death</u>. Notwithstanding any provision in the Plan to the contrary, if a Participant dies while providing service to the Company or any Subsidiary or Affiliate, any unvested Units shall immediately vest in full. The then vested portion of the Units shall be delivered to the executor or administrator of Participant's estate or, if none, to the person(s) entitled to receive the vested Units under Participant's will or the laws of descent or distribution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.<u>Participant's Disability</u>. Notwithstanding any provision in the Plan to the contrary, if a Participant terminates service from the Company or any Subsidiary or Affiliate due to Disability, any unvested Units shall immediately vest in full. "<u>Disability</u>" shall mean that the Participant, due to physical or mental illness, is considered disabled under the Company's long-term disability insurance plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.<u>Participant's Retirement</u>. If the Participant's status as an employee of the Company or any Subsidiary or Affiliate terminates by reason of a Covered Retirement, as defined below, unvested Units will remain outstanding and continue to vest and be settled on each remaining Vesting Date without regard to the requirement that the Participant be employed by the Company or any Subsidiary or Affiliate. For purposes hereof, a "<u>Covered Retirement</u>" is the voluntary termination of a Retirement Eligible Individual who has provided the Company not less than six months' prior notice of such employee's intent to retire from the Company or any Subsidiary or Affiliate; provided, however, the Chief Executive Officer may waive the six-month notice period or allow an earlier retirement date with the consent of the Participant, provided that the Compensation Committee must approve the waiver for the Chief Executive Officer. A "<u>Retirement Eligible Individual</u>" means an employee of the Company or any Subsidiary or Affiliate who has attained at least 55 years of age and who has a combined age and years of credited employment service with the Company and/or any Subsidiary or Affiliate of 65 years. Notwithstanding the foregoing, any Covered Retirement that occurs prior to the first Vesting Date shall result in forfeiture of all unvested Units.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.<u>Qualifying Termination</u>. Upon a Qualifying Termination, any unvested Units scheduled to vest within six months following the Participant's Termination Date shall vest immediately in full on the Participant's Termination Date. "<u>Qualifying Termination</u>" shall mean, with respect to the Participant, an involuntary termination of employment without Cause by the Company or any Subsidiary or Affiliate other than a termination by reason of death, Disability, Covered Retirement, or related to a Change-in-Control (and covered by Section 4(f) below). "<u>Cause"</u> as a reason for a Participant's termination of employment as an employee shall have the meaning assigned such term in the employment agreement, if any, between such Participant and the Company or any Subsidiary or Affiliate; <u>provided</u>, <u>however</u>, that if there is no such employment agreement in which such term is defined, "<u>Cause</u>" shall mean (i) the Participant's willful and continued failure to perform his or her duties with the Company or any Subsidiary or Affiliate (other than any such failure resulting from incapacity due to physical or mental illness, and specifically excluding any failure by the Participant, after reasonable efforts, to meet performance expectations), or (ii) the willful engaging by the Participant in illegal conduct, gross misconduct, or conduct in violation of Company policies. For purposes of this provision, no act or failure to act, on the part of the Participant, shall be considered "willful" unless it is done, or omitted to be done, by the Participant in bad faith or without reasonable belief that his or her action or omission was in the best interests of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f.<u>Chan</u>g<u>e-in-Control</u>. In the event of a Change-in-Control, the Units will convert to Units of the acquiring entity or continuing entity, as applicable, and vest in accordance with the schedule set forth above; provided, however, that the Units:

 2 <br>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;Will automatically accelerate and vest in full if within the 24-month period following the Change-in-Control, if the Participant is terminated by the Company or the acquiring or continuing entity or any Subsidiary or Affiliates without Cause; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;Will automatically accelerate and vest in full at the Change-in-Control if this Award Agreement is not assumed or replaced by the acquiring or continuing entity.

In addition to a Change-in-Control event as defined in the Plan, a Change-in-Control for purposes of this Agreement shall include the divestiture of the business unit of the Participant.

5.<u>Restrictive Covenants and Remedies</u>. Participant agrees to the restrictive covenants contained in this Section 5 (the "<u>Restrictive Covenants</u>") and agrees that the Restrictive Covenants and the remedies described herein are reasonable and necessary to protect the legitimate interests of the Company. If any provision of this Section 5, or the application thereof to any person or circumstance, is determined to be invalid, illegal, or unenforceable in any respect under applicable law, such provision shall be modified and enforced to the maximum extent permitted by law so as to effect the intent of the parties. If such provision cannot be so modified, it shall be severed from this Agreement, and the remaining provisions shall remain in full force and effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.<u>Confidentiality</u>. The Participant agrees, during their employment with the Company and thereafter, to maintain the confidentiality of the Company's Confidential Information and to use such Confidential Information for the exclusive benefit of the Company. "<u>Confidential Information</u>" will be interpreted as broadly as possible to include all information of any sort (whether merely remembered or embodied in a tangible or intangible form) that is (1) related to Company's or any Subsidiary's or Affiliate's current or potential business and (2) is not generally or publicly known.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.<u>Competing Activity</u>. During the Participant's employment with the Company and for one (1) year following termination of the Participant's employment with the Company for any reason whatsoever, the Participant shall not compete, directly or indirectly, in any manner or capacity, with the Company. Competing activity shall include any business engaged (whether directly or indirectly) in the design, manufacture, marketing, or sale of products or services competitive with those designed, manufactured, marketed, or sold by the Company or any Subsidiary or Affiliate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.<u>Non-Solicitation of Employees</u>. During the Participant's employment with the Company and for two (2) years following termination of the Participant's employment with the Company for any reason whatsoever, the Participant shall not, directly or indirectly, solicit or encourage any person who was an employee of the Company or any Subsidiary or Affiliate during Participant's employment, to leave employment with the Company or in any way interfere adversely with the relationship between any such employee and the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.<u>Non-Solicitation of Customers or Vendors</u>. During the Participant's employment with the Company and for two (2) years following termination of the Participant's employment with the Company for any reason whatsoever, the Participant shall not, directly or indirectly, solicit or divert the business of the Company's customers or vendors who were customers or vendors to the Company during Participant's employment or in any way interfere adversely with the business relationship between any such customer or vendor and the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.<u>Partial Invalidity</u>. If any portion of this Section 5 is determined to be unenforceable in any respect, it shall be interpreted to be valid to the maximum extent for which it reasonably may be enforced. The Participant acknowledges the uncertainty of the law in this respect and expressly stipulate that this Award Agreement is to be given the construction that renders its provisions valid and enforceable to the maximum extent (not exceeding its express terms) possible under applicable law.

 3 <br>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f.<u>Remedy for Breach</u>. The Participant agrees that a breach of any of the Restrictive Covenants would cause material and irreparable harm to the Company that would be difficult or impossible to measure, and that monetary damages for any such harm would, therefore, be an inadequate remedy. Accordingly, Participant agrees that if they breach any Restrictive Covenant, the Company shall be entitled, in addition to and without limitation upon all other remedies the Company may have under this Award Agreement, at law or otherwise, to obtain injunctive or other appropriate equitable relief.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g.<u>Clawback</u>. The Participant acknowledges that the award is subject to the Company's clawback policy, as in effect from time to time. The Committee may, in accordance with the Plan and any applicable clawback policy and in its sole discretion, provide for cancellation of any or all of the Participant's outstanding awards or forfeiture by the Participant of any gain realized in respect of awards, and repayment of any such gain promptly to the Company.

6.<u>Non-Transferability</u>. This Agreement or the rights hereunder may not be transferred.

7.<u>No Security Holder Rights</u>. Participant shall have no rights as a security holder with respect to the unvested Ordinary Shares covered by the Units.

8.<u>No Dividends</u>. Participant shall not be entitled to receive dividends or dividend equivalents with respect to the number of unvested Ordinary Shares covered by the Units.

9.<u>Taxes</u>. Participant acknowledges that the Company has the right to require Participant to remit to the Company an amount sufficient to satisfy his or her minimum federal, state, local and foreign withholding tax requirements, or to deduct from all payments under the Plan amounts sufficient to satisfy such withholding tax requirements. Participant further acknowledges that the ultimate liability for all federal, state, local and foreign income taxes, social insurance, payroll tax, or other tax-related items related to the Participant's participation in the Plan is and remains the Participant's responsibility and may exceed the amount actually withheld by the Company. Participant authorizes the Company and/or its Subsidiaries or Affiliates, or their respective agents, at their discretion, to satisfy the Participant's tax obligations that must be withheld by the Company and/or its Subsidiaries or Affiliates by withholding in Ordinary Shares to be issued upon vesting of the Units, or in the sole discretion of the Company, by any other appropriate method.

With respect to a Retirement Eligible Individual, the Company may, in its discretion, accelerate the vesting and settlement of a portion of the Units to the extent necessary to pay the Federal Insurance Contributions Act (FICA) tax imposed under Sections 3101, 3121(a) and 3121(v)(2) of the Code and to pay the income tax at source on wages imposed under Section 3401 of the Code or the corresponding withholding provisions of applicable state, local or foreign tax laws as a result of the payment of the FICA tax, and to pay the additional income tax at source on wages attributable to the pyramiding section 3401 wages and taxes; provided that the total payment under this acceleration provision cannot exceed the aggregate of the FICA tax amount, and the income tax withholding related to such FICA amount (as permitted under Treasury Regulation Section 1.409A-3(j)(4)(vi); and provided further that any Units vested and settled in accordance with this Section will reduce, share-for-share, that portion of the Award that would vest on the immediately following Vesting Date. Participant authorizes the Company and/or any Subsidiary or Affiliate, or their respective agents, at their discretion, to satisfy the Participant's tax obligations that must be withheld by the Company and/or any Subsidiary or Affiliate by withholding in Ordinary Shares to be issued upon vesting of the Units, or in the sole discretion of the Company, by any other appropriate method. The Company shall delay the issuance of any Ordinary Shares upon any Vesting Date to the extent necessary to comply with Section 409A(a)(2)(B)(i) of the Code (relating to payments made to "specified employees" as a result of their separation from service) to the date that is six months and one day following the date of the Participant's separation from service (or shorter period ending on the date of the Participant's death following such separation).

 4 <br>

------

10.<u>Data Protection</u>. Participant consents to the collection and processing of Personal data relating to the Participant so that the Company and its Affiliates can fulfill their obligations and exercise their rights under the Plan and generally administer and manage the Plan. "Personal data" includes but is not be limited to, data relating to the Participant's identity, employment, participation in the Plan and securities offered or received, purchased or sold under the Plan from time to time and other related financial and contact details. Participant accepts that the Personal data will be administered and processed by the Company or any other agent or person designated by the Company. Participant is entitled to request access to the data referring to the Participant and held by the Company and to request the amendment or deletion of such data. Participant also gives express consent to the Company to transfer and process their Personal data to the United States in accordance with the applicable laws and regulations of the United States even if the level of Personal data protection in the United States may be lower than in the Participant's country. Participant acknowledges receipt of the Company's Privacy Notice, which provides additional details on data processing. Participant acknowledges that they are free to withdraw their consent at any time.

For the purposes of compliance with the General Data Protection Regulation (EU) 2016/679, Participant acknowledges that the Company will separately provide information on the collection, processing, and transfer of Personal Data.

11.<u>Language</u>. Participant acknowledges that the Plan and this Agreement are provided in English only and waives their right to translated Plan documentation.

12.<u>Discretionary Nature of Benefit; No Right to Continued Employment; No Entitlement to Future Awards</u>. Participant understands that under this Agreement, grants of Units are made at the complete discretion of the Company pursuant to the Plan. The offer to participate in the Plan does not constitute an acquired right. Nothing in this Agreement shall confer on any Participant any right to continue in the employment of the Company or its Subsidiaries or interfere in any way with the right of the Company or its Subsidiaries to terminate such Participant's employment at any time for any reason or to continue such Participant's present (or any other) rate of compensation. The grant of the Units under any award to any Participant is a one-time benefit and shall not create any rights in such Participant to any subsequent awards by the Company, no award hereunder shall be considered a condition of such Participant's employment, and no profit with respect to an award shall be considered part of such Participant's salary or compensation under any severance statute or other applicable law.

This Agreement may be executed in one or more counterparts (including by means of electronically signed or submitted signature pages), all of which taken together shall constitute one and the same Agreement.

\*&nbsp;&nbsp;&nbsp;&nbsp;\*&nbsp;&nbsp;&nbsp;&nbsp;\*&nbsp;&nbsp;&nbsp;&nbsp;\*

 5 <br>

------

IN WITNESS WHEREOF, the Company, acting by and through its duly authorized officers, has executed this Award Agreement effective as of the date first above written.

SENSATA TECHNOLOGIES HOLDING PLC

By:

![image_01.jpg](image_01.jpg)

__________________________<br>Name: &nbsp;&nbsp;&nbsp;&nbsp;Stephan von Schuckmann<br>Title:&nbsp;&nbsp;&nbsp;&nbsp;CEO

Accepted and Agreed:

____________________________%%FIRST_NAME%-% %%LAST_NAME%-%

 6 <br>

## Exhibit 10.3

AWARD AGREEMENT

SENSATA TECHNOLOGIES HOLDING PLC<br>(the "<u>Company</u>")

**PERFORMANCE RESTRICTED STOCK UNITS** 

Date: %%OPTION_DATE,'Month DD, YYYY'%-% ("<u>Grant Date</u>")

Issue to:

%%FIRST_NAME%-% %%LAST_NAME%-% ("<u>Participant</u>")

&nbsp;&nbsp;&nbsp;&nbsp;%%TOTAL_SHARES_GRANTED,'999,999,999'%-% Performance Restricted Stock Units of the Company (the "<u>PRSUs</u>"). Each PRSU represents the right to potentially receive one Ordinary Share, par value €0.01 per Ordinary Share.

The foregoing PRSUs are "Performance Awards" as such term is in the Company's 2021 Equity Incentive Plan, as may be amended from time to time (the "<u>Plan</u>"), and such Performance Awards are subject to all of the terms and conditions of the Plan in effect from time to time, except as otherwise provided herein. Any capitalized term used herein and not otherwise defined shall have the meaning ascribed to such term in the Plan. For valuable consideration, receipt of which is acknowledged, Participant agrees to the following additional terms and conditions.

**PRSU Terms and Conditions**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.<u>Plan Incorporated by Reference</u>. This Award Agreement (this "<u>Agreement</u>") is subject to to the terms of the Plan and may be amended as provided in the Plan. This Agreement does not set forth all of the terms and conditions of the Plan, which are incorporated herein by reference. The Committee administers the Plan and its determinations regarding the operation of the Plan are final and binding. Copies of the Plan may be obtained upon written request without charge from the Legal Department of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Definitions. For purposes of this Agreement, the following terms shall have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a."<u>Peer Company</u>" shall mean each of the companies listed on <u>Annex A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b."<u>Peer Group</u>" means the companies listed on <u>Annex A</u> attached hereto, which will be amended to remove any Peer Company that is acquired (whether through merger, stock purchase or purchase of substantially all the assets of the company) or ceases to operate (whether through bankruptcy, insolvency or sale) during the Performance Period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c."<u>Performance Period</u>" means January 1, 2026 through December 31, 2028.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d."<u>Relative Total Shareholder Return Performance</u>" or "<u>rTSR Performance</u>" means the Company's TSR when ranked among the TSR of the Peer Group during the Performance Period (e.g. the Company's TSR ranks 4th out of 12 Peer Companies during the Performance Period, the rTSR Performance will be the 75<sup>th</sup> percentile).

 <br> <br>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e."<u>ROIC</u>" means Return on Invested Capital and is a percentage calculated by dividing NOPAT by Total Invested Capital where (1) NOPAT means adjusted EBIT minus adjusted taxes and (2) Total Invested Capital means (i) Average Trailing 5 Quarters of Shareholder Equity, Total Long-Term Debt, and Deferred Taxes plus (ii) Long-Term Capital Leases & Other Obligations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f."<u>Target</u>" means 100% of the PRSUs granted under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g."<u>TSR</u>" means Total Shareholder Return and is calculated in accordance with Item 201(e) of Regulation S-K. Specifically, TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the registrant's share price at the end and the beginning of the measurement period, by the share price at the beginning of the measurement period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h."<u>Vesting Date</u>" means the third anniversary of the Grant Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.<u>Vesting of PRSUs; Issuance of Ordinary Shares</u>. Except as may be set forth in Section 4 below, the PRSUs (or a portion thereof) shall vest upon meeting the performance criteria described in this Agreement on the Vesting Date, provided the Participant remains employed by the Company or one of its Subsidiaries continuously through the Vesting Date. The number of PRSUs that will vest and the number of Ordinary Shares to be issued to the Participant on the Vesting Date will be determined based upon the Company's achievement of the performance goals, inclusive of rTSR and ROIC, as set forth in Table 1 below:

**TABLE 1: RELATIVE TSR AND ROIC PERFORMANCE DURING THE PERFORMANCE PERIOD**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **rTSR accounts for 50% of PRSU award** | **rTSR** | **Vested Shares Scale** | **ROIC accounts for 50% of PRSU award** | **ROIC** | **Vested Shares Scale** |
| **rTSR accounts for 50% of PRSU award** | <33<sup>rd</sup> %ile | 0% | **ROIC accounts for 50% of PRSU award** | <11.0% | 0% |
| **rTSR accounts for 50% of PRSU award** | 33<sup>rd</sup> %ile | 50% | **ROIC accounts for 50% of PRSU award** | 11.0% | 50% |
| **rTSR accounts for 50% of PRSU award** | 50th %ile | 100% | **ROIC accounts for 50% of PRSU award** | 11.7% | 100% |
| **rTSR accounts for 50% of PRSU award** | 66<sup>th</sup> %ile | 150% | **ROIC accounts for 50% of PRSU award** | 12.4% | 150% |
| **rTSR accounts for 50% of PRSU award** | 80th %ile | 200% | **ROIC accounts for 50% of PRSU award** | 13.1% | 200% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.<u>Vesting on Termination of Employment, Death, Disability, Retirement and Change in Control.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.<u>General</u>. Unless otherwise provided in this Section 4, any unvested PRSUs shall be forfeited immediately upon the date that Participant terminates his or her service with the Company or any Subsidiary or Affiliate or otherwise ceases to be a Participant Eligible to Vest ("<u>Termination Date</u>"). Unless otherwise expressly provided in this Agreement or determined by the Committee or its designee, Participant's right to vest in the PRSUs under the Plan, if any, will terminate as of such Termination Date and will not be extended by any notice period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.<u>Participant's Death</u>. Notwithstanding any provision in the Plan to the contrary, if a Participant dies while providing service to the Company or any Subsidiary or Affiliate, the PRSUs shall immediately vest in an amount equal to the greater of (i) Target or (ii) actual performance at the time of termination based on the Committee's determination. The vested portion of the PRSUs shall be delivered to the executor or administrator of Participant's estate or, if none, to

 2 <br>

------

the person(s) entitled to receive the vested PRSUs under Participant's will or the laws of descent or distribution, and the unvested portion of the PRSUs shall be forfeited.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.<u>Participant's Disability</u>. Notwithstanding any provision in the Plan to the contrary, if a Participant terminates service from the Company or any Subsidiary or Affiliate due to Disability, the PRSUs shall immediately vest in an amount equal to the greater of (i) Target or (ii) actual performance at the time of termination based on the Committee's determination. "<u>Disability</u>" shall mean that the Participant, due to physical or mental illness, is considered disabled under the Company's long-term disability insurance plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.<u>Participant's Retirement</u>. If the Participant's status as an employee of the Company or any Subsidiary or Affiliate terminates by reason of a Covered Retirement, as defined below, the PRSUs shall vest and be settled on the Vesting Date in an amount equal to actual performance at the end of the Performance Period. For purposes hereof, a "<u>Covered Retirement</u>" is the voluntary termination of a Retirement Eligible Individual who has provided the Company not less than six months prior notice of such employee's intent to retire from the Company or any Subsidiary or Affiliate; provided, however, the Chief Executive Officer may waive the six-month notice period or allow an earlier retirement date with the consent of the Participant, provided that the Compensation Committee must approve the waiver for the Chief Executive Officer. A "<u>Retirement Eligible Individual</u>" means an employee of the Company or any Subsidiary or Affiliate who has attained at least 55 years of age and who has a combined age and years of credited employment service with the Company and/or all Affiliates of 65 years. Notwithstanding the foregoing, any Covered Retirement that occurs prior to the first anniversary of the Grant Date shall result in forfeiture of all unvested PRSUs .

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.<u>Qualifying Termination</u>. Upon a Qualifying Termination, any unvested PRSUs scheduled to vest within six months of the Participant's Termination Date shall vest and be settled on the Vesting Date in an amount equal to actual performance at the end of the Performance Period and pro-rated for time served in the Performance Period (number of days employed during the Performance Period divided by number of days in the Performance Period). "<u>Qualifying Termination</u>" shall mean, with respect to the Participant, an involuntary termination of employment without Cause by the Company or any Subsidiary or Affiliate other than a termination by reason of death, Disability, Covered Retirement, or related to a Change-in-Control (and covered by Section 4(f) below). Cause as a reason for a Participant's termination of employment as an employee shall have the meaning assigned such term in the employment agreement, if any, between such Participant and the Company or any Subsidiary or Affiliate; provided, however, that if there is no such employment agreement in which such term is defined, "Cause" shall mean (i) the Participant's willful and continued failure to perform his or her duties with the Company or any Subsidiary or Affiliate (other than any such failure resulting from incapacity due to physical or mental illness, and specifically excluding any failure by the Participant, after reasonable efforts, to meet performance expectations), or (ii) the willful engaging by the Participant in illegal conduct, gross misconduct, or conduct in violation of Company policies. For purposes of this provision, no act or failure to act, on the part of the Participant, shall be considered "willful" unless it is done, or omitted to be done, by the Participant in bad faith or without reasonable belief that his or her action or omission was in the best interests of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f.<u>Chan</u>g<u>e in Control</u>. In the event of a Change in Control, the PRSUs will convert to time-based RSUs based on the greater of (i) the actual performance at the time of the Change in Control based on the Committee's determination or (ii) Target. Vesting of the time-based RSUs will assume the vesting schedule of the original PRSU award. The time-based RSUs as so converted:

 3 <br>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.Will automatically accelerate and vest in full if within the 24-month period following the Change in Control, if the Participant is terminated by the Company or the continuing entity or any of its Affiliates without Cause;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.Will automatically accelerate and vest in full at the Change in Control if this Agreement is not assumed or replaced by the acquirer/continuing entity or replaced by other terms or awards deemed by the Compensation Committee to be appropriate; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii.Will vest on the third anniversary of the Grant Date, if vesting has not otherwise been accelerated as provided above.

In addition to a Change-in-Control event as defined in the Plan, a Change-in-Control for purposes of this Agreement shall include the divestiture of the business unit of the Participant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.<u>Restrictive Covenants and Remedies</u>. Participant agrees to the restrictive covenants contained in this Section 5 (the "<u>Restrictive Covenants</u>") and agrees that the Restrictive Covenants and the remedies described herein are reasonable and necessary to protect the legitimate interests of the Company. If any provision of this Section 5, or the application thereof to any person or circumstance, is determined to be invalid, illegal, or unenforceable in any respect under applicable law, such provision shall be modified and enforced to the maximum extent permitted by law so as to effect the intent of the parties. If such provision cannot be so modified, it shall be severed from this Agreement, and the remaining provisions shall remain in full force and effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.<u>Confidentiality</u>. The Participant agrees, during their employment with the Company and thereafter, to maintain the confidentiality of the Company's Confidential Information and to use such Confidential Information for the exclusive benefit of the Company. "<u>Confidential Information</u>" will be interpreted as broadly as possible to include all information of any sort (whether merely remembered or embodied in a tangible or intangible form) that is (1) related to Company's or any Subsidiary's or Affiliate's current or potential business and (2) is not generally or publicly known.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.<u>Competing Activity</u>. During the Participant's employment with the Company and for one (1) year following termination of the Participant's employment with the Company for any reason whatsoever, the Participant shall not compete, directly or indirectly, in any manner or capacity, with the Company. Competing activity shall include any business engaged (whether directly or indirectly) in the design, manufacture, marketing, or sale of products or services competitive with those designed, manufactured, marketed, or sold by the Company or any Subsidiary or Affiliate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.<u>Non-Solicitation of Employees</u>. During the Participant's employment with the Company and for two (2) years following termination of the Participant's employment with the Company for any reason whatsoever, the Participant shall not, directly or indirectly, solicit or encourage any person who was an employee of the Company or any Subsidiary or Affiliate during Participant's employment, to leave employment with the Company or in any way interfere adversely with the relationship between any such employee and the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.<u>Non-Solicitation of Customers or Vendors</u>. During the Participant's employment with the Company and for two (2) years following termination of the Participant's employment with the Company for any reason whatsoever, the Participant shall not, directly or indirectly, solicit or divert the business of the Company's customers or vendors who were customers or vendors to the Company during Participant's employment or in any way interfere adversely with the business relationship between any such customer or vendor and the Company.

 4 <br>

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.<u>Partial Invalidity</u>. If any portion of this Section 5 is determined to be unenforceable in any respect, it shall be interpreted to be valid to the maximum extent for which it reasonably may be enforced. The Participant acknowledges the uncertainty of the law in this respect and expressly stipulate that this Award Agreement is to be given the construction that renders its provisions valid and enforceable to the maximum extent (not exceeding its express terms) possible under applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f.<u>Remedy for Breach</u>. The Participant agrees that a breach of any of the Restrictive Covenants would cause material and irreparable harm to the Company that would be difficult or impossible to measure, and that monetary damages for any such harm would, therefore, be an inadequate remedy. Accordingly, Participant agrees that if they breach any Restrictive Covenant, the Company shall be entitled, in addition to and without limitation upon all other remedies the Company may have under this Award Agreement, at law or otherwise, to obtain injunctive or other appropriate equitable relief.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g.<u>Clawback</u>. The Participant acknowledges that the award is subject to the Company's clawback policy, as in effect from time to time. The Committee may, in accordance with the Plan and any applicable clawback policy and in its sole discretion, provide for cancellation of any or all of the Participant's outstanding awards or forfeiture by the Participant of any gain realized in respect of awards, and repayment of any such gain promptly to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.<u>Non-Transferability</u>. This Agreement or the rights hereunder may not be transferred.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.<u>No Dividends</u>. Participant shall not be entitled to receive dividends or dividend equivalents with respect to the number of unvested Ordinary Shares covered by the PRSUs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.<u>No Security Holder Rights</u>. Participant shall have no rights as a security holder with respect to the unvested Ordinary Shares covered by the PRSUs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.<u>Taxes</u>. Participant acknowledges that the Company has the right to require Participant to remit to the Company an amount sufficient to satisfy his or her minimum federal, state, local and foreign withholding tax requirements, or to deduct from all payments under the Plan amounts sufficient to satisfy such minimum withholding tax requirements. Participant further acknowledges that the ultimate liability for all federal, state, local and foreign income taxes, social insurance, payroll tax, or other tax-related items related to the Participant's participation in the Plan is and remains the Participant's responsibility and may exceed the amount actually withheld by the Company. Participant authorizes the Company and/or its Subsidiaries, or their respective agents, at their discretion, to satisfy the Participant's tax obligations that must be withheld by the Company and/or its Subsidiaries by withholding in Ordinary Shares to be issued upon vesting of the PRSUs, or in the sole discretion of the Company, by any other appropriate method.

With respect to a Retirement Eligible Individual, the Company may, in its discretion, accelerate the vesting and settlement of a portion of the Units to the extent necessary to pay the Federal Insurance Contributions Act (FICA) tax imposed under Sections 3101, 3121(a) and 3121(v)(2) of the Code and to pay the income tax at source on wages imposed under Section 3401 of the Code or the corresponding withholding provisions of applicable state, local or foreign tax laws as a result of the payment of the FICA tax, and to pay the additional income tax at source on wages attributable to the pyramiding section 3401 wages and taxes; provided that the total payment under this acceleration provision cannot exceed the aggregate of the FICA tax amount, and the income tax withholding related to such FICA amount (as permitted under Treasury Regulation Section 1.409A-3(j)(4)(vi); and provided further that any Units vested and settled in accordance with this Section will reduce, share-for-share, that portion of the Award that would vest on the immediately following Vesting Date. Participant authorizes the Company and/or any Subsidiary or Affiliate, or their respective agents, at their discretion, to satisfy the Participant's tax obligations

 5 <br>

------

that must be withheld by the Company and/or any Subsidiary or Affiliate by withholding in Shares to be issued upon vesting of the Units, or in the sole discretion of the Company, by any other appropriate method. The Company shall delay the issuance of any Shares upon any Vesting Date to the extent necessary to comply with Section 409A(a)(2)(B)(i) of the Code (relating to payments made to "specified employees" as a result of their separation from service) to the date that is six months and one day following the date of the Participant's separation from service (or shorter period ending on the date of the Participant's death following such separation).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.<u>Data Protection</u>. Participant consents to the collection and processing of Personal data relating to the Participant so that the Company and its Affiliates can fulfill their obligations and exercise their rights under the Plan and generally administer and manage the Plan. "Personal data" includes but is not be limited to, data relating to the Participant's identity, employment, participation in the Plan and securities offered or received, purchased or sold under the Plan from time to time and other related financial and contact details. Participant accepts that the Personal data will be administered and processed by the Company or any other agent or person designated by the Company. Participant is entitled to request access to the data referring to the Participant and held by the Company and to request the amendment or deletion of such data. Participant also gives express consent to the Company to transfer and process their Personal data to the United States in accordance with the applicable laws and regulations of the United States even if the level of Personal data protection in the United States may be lower than in the Participant's country. Participant acknowledges receipt of the Company's Privacy Notice, which provides additional details on data processing. Participant acknowledges that they are free to withdraw their consent at any time.

For the purposes of compliance with the General Data Protection Regulation (EU) 2016/679, Participant acknowledges that the Company will separately provide information on the collection, processing, and transfer of Personal Data.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.<u>Language</u>. Participant acknowledges that the Plan and this Agreement are provided in English only and waives their right to translated Plan documentation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.<u>Discretionary Nature of Benefit; No Right to Continued Employment; No Entitlement to Future Awards</u>. Participant understands that under this Agreement, grants of PRSUs are made at the complete discretion of the Company pursuant to the Plan. The offer to participate in the Plan does not constitute an acquired right. Nothing in this Agreement shall confer on any Participant any right to continue in the employment of the Company or its Subsidiaries or interfere in any way with the right of the Company or its Subsidiaries to terminate such Participant's employment at any time for any reason or to continue such Participant's present (or any other) rate of compensation. The grant of the PRSUs under any award to any Participant is a one-time benefit and shall not create any rights in such Participant to any subsequent awards by the Company, no award hereunder shall be considered a condition of such Participant's employment, and no profit with respect to an award shall be considered part of such Participant's salary or compensation under any severance statute or other applicable law.

This Agreement may be executed in one or more counterparts (including by means of electronically signed or submitted signature pages), all of which taken together shall constitute one and the same Agreement.

\*&nbsp;&nbsp;&nbsp;&nbsp;\*&nbsp;&nbsp;&nbsp;&nbsp;\*&nbsp;&nbsp;&nbsp;&nbsp;\*

 6 <br>

------

IN WITNESS WHEREOF, the Company, acting by and through its duly authorized officers, has executed this Agreement effective as of the date first above written.

SENSATA TECHNOLOGIES HOLDING PLC

By:

![image_0.jpg](image_0.jpg)

__________________________<br>Name: Stephan von Schuckmann<br>Title: CEO

Accepted and Agreed:

____________________________%%FIRST_NAME%-% %%LAST_NAME%-%

 7 <br>

------

<u>Annex A</u>

<u>Peer Group</u>

---

| | | |
|:---|:---|:---|
| Adient PLC (ADNT) | BorgWarner, Inc. (BWA) | Donaldson Company Inc. (DCI) |
| Gentex Corporation (GNTX) | Gentherm Incorporated (THRM) | Cognex Corp (CGNX) |
| Lear Corporation (LEA) | Littelfuse, Inc. (LFUS) | Regal Rexnord Corp (RRX) |
| Stoneridge, Inc. (SRI) | TE Connectivity Ltd (TEL) | Visteon Corporation (VC) |

---

 8 <br>

## Exhibit 31.1

**Exhibit 31.1** 

**Certification** 

I, Stephan von Schuckmann, certify that:

1. I have reviewed the quarterly report on Form 10-Q of Sensata Technologies Holding plc;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | April 28, 2026 | |
| | | /s/ STEPHAN VON SCHUCKMANN |
| | | **Stephan von Schuckmann** |
| | | **Chief Executive Officer** |

---

## Exhibit 31.2

**Exhibit 31.2** 

**Certification** 

I, Andrew Lynch, certify that:

1. I have reviewed the quarterly report on Form 10-Q of Sensata Technologies Holding plc;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | April 28, 2026 | |
| | | /s/ ANDREW LYNCH |
| | | **Andrew Lynch** |
| | | **Executive Vice President and Chief Financial Officer** |

---

## Exhibit 31.3

**Exhibit 31.3** 

**Certification** 

I, Richard Siedel, certify that:

1. I have reviewed the quarterly report on Form 10-Q of Sensata Technologies Holding plc;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | April 28, 2026 | |
| | | /s/ RICHARD SIEDEL |
| | | **Richard Siedel** |
| | | **Senior Vice President and Chief Accounting Officer** |

---

## Exhibit 32.1

**Exhibit 32.1** 

**CERTIFICATION PURSUANT TO** 

**18 U.S.C. 1350** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report on Form 10-Q of Sensata Technologies Holding plc (the "Company") for the quarter ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned chief executive officer, chief financial officer, and chief accounting officer of the Company, certifies, to the best knowledge and belief of the signatory, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| | /s/ STEPHAN VON SCHUCKMANN |
| | **Stephan von Schuckmann** |
| | **Chief Executive Officer** |
| Date: | April 28, 2026 |
|  | /s/ ANDREW LYNCH |
|  | **Andrew Lynch** |
|  | **Executive Vice President and Chief Financial Officer** |
| Date: | April 28, 2026 |
|  | /s/ RICHARD SIEDEL |
|  | **Richard Siedel** |
|  | **Senior Vice President and Chief Accounting Officer** |
| Date: | April 28, 2026 |

---

<br>